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Summary 
This thesis consists of a series of studies utilising quantitative ultrasound (Sunlight Omnisense 
7000P) to assess bone health of infants. Preterm infants are at risk of osteopenia of prematurity 
(OP) which can result in fractures in the short term and may have an impact on growth in 
infancy and childhood. OP has a multifactorial aetiology including factors such as poor 
mineral intake and immobility. There is an increasing number of ex-preterm survivors 
therefore morbidity becomes more important. There is also increasing evidence from 
epidemiological studies that growth in infancy can have an effect on adult diseases such as 
osteoporosis. 
 
The first study was a cross-sectional study of bone quantitative ultrasound measurements in 
110 term and preterm infants shortly after birth. Speed of sound (SOS) was measured at the 
tibial and the radius. This validated the technique showing reproducible measurements with 
low inter and intra-observer error, and also showed no benefit to measuring multiple sites. 
Preterm infants were found to have a significantly lower SOS than term infants. There was a 
positive correlation between tibial SOS and gestation, with birthweight being a less significant 
factor than gestation. 
 
The second study followed 18 preterm infants longitudinally from birth to hospital discharge 
or term corrected gestational age (CGA). SOS fell significantly with time in all infants. The 
most preterm infants had the greatest fall in SOS. SOS at the end of the study period was 
negatively associated with peak serum alkaline phosphatase and severity of illness score. SOS 
was significantly lower in the infants who required total parenteral nutrition for longer than 3 
weeks. These results show that the neonatal course has a significant impact on SOS trajectory. 
 
 19 
When preterm infants were followed up in the out-patient clinic over the first two years of life 
the SOS measurements taken as the next part of this study showed a catch up phenomenon. In 
the majority of infants, but not all infants, SOS moved into the normal range by 6 months 
CGA. In the subgroup of infants followed longitudinally those with the lowest SOS at hospital 
discharge/term corrected age had the greatest increase in SOS over time. 
 
An interventional study of passive exercise was performed to explore its role in influencing 
the bone health of preterm infants. Thirty one infants born at less than 33 weeks gestation 
were randomised to receive range of motion flexion and extension exercises once daily for 5 
days each week starting ‘early’(n=15) or ‘late’ (when on 100kcal/kg/day enteral feeds, n=16) 
and continuing until term corrected gestational age (CGA) or discharge from hospital. Tibial 
SOS declined significantly from birth to end of physical activity in both ‘early’ and ‘late’ 
groups, and this was similar to the decrease seen in a group of historical controls from the 
earlier longitudinal study. Weight gain and head growth did not show a significant difference 
between groups or between study infants and controls. No infant was reported to have 
sustained a fracture, and length of hospital stay was not significantly different between groups. 
There was no significant increase in sepsis rate, retinopathy of prematurity or chronic lung 
disease in study infants but numbers were small. On longer term follow-up the intervention 
was not associated with any adverse effects. 
 
To investigate the possibility that the maternal environment plays an important role in 
influencing infants’ bone health we also studied SOS changes in 188 pregnant women and 
their offspring. Most women had SOS in the normal range antenatally, and there was no 
significant change in SOS across pregnancy in the group as a whole. There was a significant 
negative correlation with SOS SDS and BMI in early pregnancy. Women who smoked 
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cigarettes had lower SOS throughout pregnancy and so did their infants. Serum bone 
biochemistry was measured in the women antenatally and after delivery, and umbilical cord 
blood was also taken where possible. Vitamin D deficiency was found to be common at the 
end of pregnancy. Women of Asian origin had significantly lower vitamin D levels at all 
stages of pregnancy. There was no significant relationship between maternal and infant SOS, 
or between maternal vitamin D status and infant SOS. 
 
The work of this thesis establishes quantitative ultrasound as a useful technique in the 
assessment of infant bone health. It is a radiation free tool which provides precise and 
reproducible measurements in both term and preterm infants. In agreement with a small 
number of other studies we found that preterm infants have a lower speed of sound at birth 
compared to term infants; speed of sound increases with increasing gestation while in utero. 
By including infants who were both appropriately grown and small for gestational age we 
found maturity to be a more important factor in bone strength than birthweight. Despite the 
apparent self limiting nature of osteopenia of prematurity an intervention to improve neonatal 
bone health is still desirable, to prevent fractures. Our results do not substantiate conclusions 
from previous studies that physical activity alone can improve neonatal bone health. .Findings 
are however limited by the small sample size.  Further studies are needed which investigate 
alternative exercise regimens, taking into account mineral and nutrient supply. Vitamin D 
deficiency, smoking and obesity may adversely affect bone health of women and their 
offspring. In the west of Scotland vitamin D deficiency is common in pregnancy: women of 
south asian origin are at particularly high risk, and should be supplemented with Vitamin D. 
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Chapter 1  Hypotheses and Aims of the Thesis 
The present studies were designed to investigate early life determinants of infant bone health. 
Using a number of techniques including quantitative ultrasound, the studies assessed bone 
health in term and preterm infants, and pregnant mothers.  
1. Hypothesis: Quantitative ultrasound may be a useful adjunct for assessing bone health 
in neonates, including the sick preterm infant. 
Aim: Assess the feasibility and reliability of the technique of quantitative ultrasound 
in neonates. 
2. Hypothesis: The neonatal course has an effect on bone development which can be 
assessed by quantitative ultrasound.  
Aim: Evaluate bone health of preterm infants at birth and during infancy, including 
use of quantitative ultrasound. 
3. Hypothesis: The maternal environment, postnatal environment and genetic factors will 
all have a role in infants bone health.   
Aim: Investigate the determinants of maternal bone health during pregnancy, and the 
link between these and infant bone health. 
4. Hypothesis: Skeletal growth is driven by functional requirements therefore the 
intervention of passive exercise in preterm neonates will improve their bone health. 
 Aim: Assess passive exercise as an intervention for improving bone health in 
 preterm infants. 
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Chapter 2 Introduction 
Section 1 Neonatal bone health  
Optimal bone health is dependent on achieving adequate bone mass, mineral content and 
geometry and these are influenced by a number of factors that can be broadly divided into 
three categories: genetics, maternal environment and the postnatal environment. There is 
increasing evidence to support the role of these factors in determining adult bone mass (1). 
Premature restriction of the in utero process of bone mass accretion and a greater ex utero 
need for bone nutrients predisposes the preterm infant to adverse bone health. Current methods 
of assessing bone health in the neonate have a low specificity and sensitivity and with an 
increasing survival rate of very low birthweight preterm infants (2) there is a need to explore 
novel, reliable, non-invasive methods for assessing bone health in this group of patients. 
However, a thorough understanding of these issues requires some knowledge of bone 
development, especially in the context of the preterm neonate. 
 
Bone biology and development 
The embryonic primordiae of the appendicular skeleton are the limb buds, which are 
mesodermal structures covered by ectoderm. The first visible outline of the embryonic limb 
follows a condensation of mesenchymal cells which subsequently differentiate into cartilage 
cells, the chondrocytes. These cells secrete a matrix and thus produce cartilaginous models of 
the future bones. Surrounding this cartilage is the perichondrium, the outer layer of which 
becomes a connective tissue sheath while the inner cells remain pluripotential (Fig.1). This 
cartilage rudiment grows by interstitial and appositional growth, and a vascular system 
develops to invade the perichondrium. A collar of bone is then laid down around the mid-shaft 
of the bone. This ossification is a result of the inner perichondrial cells differentiating into 
bone forming cells, the osteoblasts and by this time the three regions of the developing long 
 23 
bone, diaphysis, epiphysis and metaphysis are evident. At the same time, increasing vascular 
development at the site where the cartilage cells and matrix have begun to disintegrate allows 
osteoblasts to invade the centre of the shaft to form a primary ossification centre. Trabecular 
bone is then deposited on cartilaginous remnants. In humans, primary ossification centres in 
the femur and humerus are visible by week 6 of gestation (3). 
The epiphysis contains the growth plates and is responsible for the transverse and spherical 
growth of the ends of the bone, the shaping of the articular surfaces, and the longitudinal 
growth of the metaphysis and the diaphysis. The cells within the growth plate (chondrocytes) 
go through a sequential process of cell proliferation, synthesis of extra cellular matrix, cellular 
hypertrophy, mineralization of the matrix, localized vascular invasion, and apoptosis (4). The 
growth plate replenishes itself through the germinal zone and is continually replaced with 
bone at the physeal-metaphyseal junction. Not only is the hypertrophic chondrocyte crucial for 
longitudinal growth, it also prepares the matrix for calcification and vascularisation and directs 
the mineralisation of the adjacent matrix and attracts vessels by producing vascular growth 
factors.  
The fetus has a high rate of mineral accretion, with high serum phosphate, calcium, calcitonin 
and a low PTH and low circulating levels of the active vitamin D metabolites. Approximately 
99% of body calcium and 80% of phosphorus is in the skeleton at birth, at least 80% of this 
mineral deposition occurs between 25 weeks gestation and term (5). 
At the same time as longitudinal growth, there is radial growth of the diaphysis and the 
metaphysis caused by direct apposition of cortical bone by periosteum-derived osteoblasts. 
This is coordinated closely with resorption of bone by osteoclasts on the inner cortical 
endosteal (medullary) surfaces and lateral metaphyseal surfaces to maintain the relative 
proportions of the marrow cavity to the cortices and the overall shape of the bone as it grows. 
The metaphyseal cortical bone is formed by the coalescence of peripheral endochondral 
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trabecular bone from the physis with intramembranous bone from the inner osteogenic layer of 
the periosteum. This dynamic process is under the influence of a number of intrinsic and 
extrinsic factors that include growth factors, sex steroids and external biomechanical stressors.  
Detailed studies of fetal long bones show from 21-41 weeks gestation show that the bone 
geometry changes over the gestational period such that the medullary diameter increases at a 
greater rate than the outer cortical diameter growth rate thus resulting in a wider diaphyseal 
width with a greater medullary cavity and a relatively narrower cortex (6).  Although, the 
velocity of medullary diameter growth was similar (0.05 mm/week) in three long bones (tibia, 
femur, humerus) studied, the velocity of outer cortical diameter growth was greater in the tibia 
(0.16 mm/week) than in the femur (0.14 mm/week) or humerus (0.13 mm/week). The 
diaphyseal growth rate decreased in the second half of the period studied in all three bones. 
This process of endocortical resorption and expansion of the marrow cavity, which in 
densitometric terms corresponds to a decrease in volumetric bone mineral density becomes 
even more pronounced after birth and, in densitometric terms, results in an effective reduction 
in bone density (7). Some factors such as estrogen promote endocortical bone formation and it 
is possible that premature birth may hasten the process of endocortical resorption. The change 
in geometry of the neonatal bone may be regarded as an adaptation process and defects in this 
process may predispose the infant to adverse bone health.  
Overall, skeletal development does not depend solely on bone mineral accretion but also bone 
mass accrual which may be influenced by an imbalance between bone formation and 
resorption (8) as well as mechanical stimulation which is higher in utero with the muscular 
resistance of the uterine wall, compared to movements against little resistance after birth, 
putting smaller loads on the skeleton. Furthermore, the hormonal situation is also different 
postnatally, with the abrupt cessation of the placental supply of oestrogen and other hormones.  
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Neonatal Nutrition and Growth 
Early nutrition is important as it has a short term effect on the disease course i.e. the baby’s 
progress within the neonatal unit and it has an impact on long term health and development, 
particularly long term neurodevelopment. Achieving good nutrition and growth is particularly 
challenging in preterm infants. Infants born very prematurely, before 32 weeks gestation are 
likely to need total parenteral nutrition (TPN), at least in the initial period after birth. Calcium 
and phosphate are included in TPN at much smaller amounts than would be available to the 
baby from the placenta during the third trimester. This is because their solubility product is 
readily excreted and they precipitate out, their solubility depends on the acidity of the solution, 
and thus also on the protein of the solution so maximising protein can help to increase the 
amount of calcium and phosphate that can be given. This poor availability of calcium and 
phosphate, along with other factors can lead to osteopenia of prematurity. Once enteral feeds 
are established, human milk alone does not meet the nutritional requirements of a preterm 
infant and requires supplementation (9); however there is evidence for EBM reducing 
morbidity and mortality compared to using formula alone (10;11)  
Multinutrient fortifiers or using a combination of EBM with preterm formula can be used to 
increase the protein, energy, calcium and phosphate intake. No randomized trials have been 
conducted on preterm infants breastfed exclusively post discharge from hospital, however 
there is some evidence that lower weight gain, lower bone mineral content along with lower 
serum phosphate and higher serum alkaline phosphatase occurs compared to those preterm 
infants fed formula (12;13). Further research is needed to determine if breast milk should be 
fortified after the preterm infant is discharged.  
There is a trend towards earlier discharge home for preterm infants, as follow up in the 
community by home liaison sisters is possible in many areas, and more attention has been 
focused on the nutritional needs of preterm infants post discharge. Post discharge formulas 
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with increased protein and minerals compared to term formulae therefore evolved. There are a 
few studies which demonstrate advantages in weight gain and length in preterm infants fed 
post discharge formula although a recent Cochrane review did not find strong evidence that 
feeding using post discharge formula conferred benefit in growth or development of preterm 
infants up to 18 months post term (14) This was limited due to inter trial differences in 
presented outcomes,  however a meta-analysis from the 2 trials (15;16) which performed 
follow up at 18 months of age show an increased length at 18 months but not weight or head 
circumference, and no difference between groups on formal developmental testing. This 
review did not cover indices of bone health. 
As calcium accretion and bone mineralization is greatest during the first year of life then lack 
of early bone mass accumulation may have later consequences in childhood growth, 
accumulation of peak bone mass and subsequent risk of osteoporosis. Calcium is not only 
important for bone growth but also for blood clotting, intracellular metabolism, muscle 
conduction, nerve conduction and cardiac function. The placenta actively transports calcium to 
the fetus, driven by a magnesium adenosine triphosphatase-dependent calcium pump. This 
enables calcium transfer to the fetus of up to 150mg/kg of fetal weight each day in the third 
trimester. Preterm infants miss out on this calcium surge during the third trimester and are 
born with lower calcium stores and therefore require more dietary calcium postnatally. The 
recommended intake of calcium for preterm infants is 120-230mg/kg/day compared to 60-80 
mg/kg/day for a term infant (17). Calcium intestinal absorption is determined by the amount of 
ingested calcium and the solubility of the calcium salt. Calcium absorption requires calcium to 
be ionized. In term infants studies have shown the calcium absorption rate approximates 
calcium retention or bone accumulation, in preterm infants calcium retention can be 48% of 
intake (18;19).There does appear to be a linear relationship between calcium retention and 
intake in preterm infants (19;20). Also, the calcium to phosphate ratio appears to be an 
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important determinant of calcium absorption and retention. In human milk there is calcium: 
phosphate ratio of 2:1 by mass. In preterm formula, a ratio of calcium: phosphate of 1.7 has 
previously been reported to be adequate for bone mineralisation of preterm infants, whereas a 
ratio of 1.4 at the same calcium concentration was not (21). Preterm formula has a ratio of 
approximately 1.9; this can be lower in term formulae. 
In term infants at birth stores of vitamin D are usually adequate unless there is significant 
maternal deficiency. As skin synthesis of vitamin D requires exposure to UV B light, and most 
preterm infants are not exposed to sunlight initially the majority of vitamin D comes from 
maternal and dietary sources. Levels of 25 hydroxyvitamin D change with gestational age and 
thus are lower in preterm than in term infants. The 2nd hydroxylation of vitamin D by the 
kidney occurs normally in preterm infants (22). Vitamin D is present in only very small 
amounts in breast milk (0.01mcg/100ml) and in larger amounts in preterm formula (1.2-2.4 
mcg/100ml.) Glucocorticoid use and the use of theophylline can affect levels and function of 
1, 25 dihydroxyvitamin D. It is recommended that vitamin D be supplemented at a dose of 
200iu/ day  in preterm infants until 6 months old (17). Dietary fats and fat soluble vitamins 
require adequate bile secretion for absorption. Deficient bile secretion in infants with chronic 
liver or biliary disease can lead to low vitamin D absorption, vitamin D deficiency, and low 
calcium absorption. 
 
Osteopenia of Prematurity 
At birth, preterm infants have low skeletal mineral stores as a consequence of delivery prior to 
completion of the third trimester when mineral accretion would be exponentially increasing. 
These infants are then often dependent on total parenteral nutrition (TPN) which has a low 
mineral content. The supply of both calcium and phosphate is low, but a critical factor leading 
to osteopenia of prematurity (OP) is lack of phosphate (23). OP ranges from mild osteopenia 
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to overt rickets with fractures. In infants with rickets frontal bossing, swelling of 
costochondral joints, ankles and wrists and decreased linear growth can occur. Even in milder 
cases disturbed mineral metabolism is followed by reduced bone mineralisation leading to 
abnormal bone remodeling and reduced linear growth. Preterm infants are frequently ill and 
immobile; this lack of mechanical stimulation may lead to less new bone formation and 
reduced osteoid. In OP, there is a combination of reduced osteoid and reduced mineral, and the 
relative deficit of these two factors may vary from one case to another. Drugs frequently used 
in the neonatal unit, such as steroids and loop diuretics can also alter bone mineralization 
(24;25).Dexamethasone, methylxanthines and frusemide have all been shown to have an effect 
on calcium regulation. Methylxanthines and frusemide increase renal calcium excretion, with 
secondary hyperparathyroidism and bone disease having been demonstrated in infants 
receiving long term frusemide therapy. (26;27) Use of frusemide has been consistently 
reported as a risk factor for fractures secondary to OP (28-31). 
Studies in the 1980’s found the incidence of radiological rickets and osteopenia in very low 
birthweight (VLBW) and extremely low birthweight (ELBW) infants to be 32% (30) and 54% 
(32) respectively. Despite improved nutrition and the regular use of oral phosphate 
supplements, fractures still occur, typically between 10 weeks and 6 months postnatal age. The 
true incidence of fractures is unknown as screening for fractures with skeletal surveys is not 
routinely undertaken. Most fractures, especially of the rib, are discovered incidentally when x-
rays are performed for other reasons. Koo et al (30) prospectively studied 78 VLBW infants 
born between 23 and 26 weeks gestation and by day 88 found fractures plus rickets in 12 out 
of the 78, and fractures without rickets in a further 7 infants. Amir et al reported a lower 
fracture incidence of 2.1% in premature infants, occurring from 3 to 23 weeks. There have 
been many changes in neonatal feeding since these studies were done, so these figures may be 
less relevant to modern practice.  More recently, two retrospective studies reported that 7% to 
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10% of VLBW infants may still be at risk of fractures (29;31) Risk factors for fracture 
identified by these studies included prolonged intravenous nutrition, cholestatic jaundice, 
bronchopulmonary dysplasia, longer duration of oxygen therapy, and prolonged use of 
frusemide. Dahlenburg et al (33) found an increased rate of fracture in preterm infants up to 2 
years old, but by age 5 years this association was no longer significant.  
 
In the short-term, OP might impair respiratory status, respiratory distress secondary to rachitic 
changes has been described (34) Bone softening and rib fractures may contribute to chest wall 
instability, respiratory distress and difficulty weaning ventilatory support (35). OP has been 
postulated to be a factor in the development of myopia of prematurity related to altered bone 
growth of the skull (36). OP seems to be a transient disease, ‘catch up’ in bone mineralisation 
has been described using SPA and DXA (37-43) however linear growth and bone strength 
may still be affected in the longer term. Studies have shown that former preterm infants tend to 
be shorter and lighter than their term counterparts (44;45) and high neonatal alkaline 
phosphatase has been significantly associated with short stature at 18 months and 10 years of 
age (45;46).  Total body BMC and cortical area of the distal tibia have been reported to be 
lower in ex preterm preschool children, even after adjusting for current body weight (47). 
Lower bone mineral content and density has also been found in school age children born 
preterm (44;48) Ex preterm children have been shown to have increased urinary calcium 
excretion at age 8 yrs associated with a reduction in height and hip bone mineral density (49). 
A recent study of young adults born prematurely showed that height and lumbar spine BMD at 
age 20 years were lower compared to UK population reference values (50). The effect of 
premature birth (with modern treatment of prematurity) on accumulation of peak bone mass 
and subsequent risk of osteoporosis merits future evaluation. 
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Biomechanical Factors and Infant Bone Health 
Stress on bone exerted by muscle is necessary for bone formation and growth. The 
mechanostat theory of a functional model of bone development suggests that bone cell action 
is coordinated by the mechanical requirements of the bone; and thus can be modified by 
influencing muscle force or longitudinal bone growth (51). Several studies have described a 
positive effect of physical activity on bone mass in children, adolescents and adults (52;53) 
Immobilisation has been demonstrated to result in low bone mineral density (54). Spontaneous 
movement has been related to changes in bone speed of sound (SOS) in three infants with 
reduced unilateral movements secondary to a contralateral brain insult (55). Tibial SOS was 
reduced in the legs with reduced spontaneous movements compared to the unaffected side. In 
controls with normal symmetrical movements tibial SOS was similar in both sides. 
Preterm infants are hypotonic and have reduced muscle bulk, particularly if they are small for 
gestational age. Sedation or paralysis to optimise mechanical ventilation reduces movement, 
and any spontaneous movements which do occur don’t meet any resistance. This is a marked 
contrast to in utero movements with strong resistance from the muscular uterine wall. Infants 
who are very unwell during the immediate neonatal period also have reduced spontaneous 
movement. In addition minimal handling of preterm infants is becoming routine in neonatal 
units, therefore there are many factors which mean preterm infants lack muscle stimulation 
and subsequently may contribute to osteopenia of prematurity. A few studies have performed 
physical activity interventions in neonates. Moyer-Mileur (56) enrolled preterm infants aged 2 
to 4 weeks old to a physical activity programme consisting of range of motion exercises with 
gentle compression, extension and flexion of both upper and lower limbs. Each movement was 
done 5 times at each joint five times each week, and the infants receiving this had at the end of 
the study period (when they had reached a weight of 2kg) a higher mean radial BMC 
measured by SPA compared to controls. The same physical activity programme was repeated 
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in 2000 (57) and the infants then assessed by DXA, infants in the exercise group had larger 
forearm bone area, but there were no differences in forearm BMC or BMD when compared to 
the control group. This study group had DXA and anthropometry followed up at 12 months 
corrected age and there were no differences detected between the intervention and control 
groups. Litmanovitz et al (58) used the same exercise protocol designed by Moyer-Mileur but 
started the physical activity when the infants were immediately cardiovascularly stable and 
continued for only 4 weeks. Over this 4 weeks there was an attenuation in the decrease in bone 
speed of sound measured by QUS in the infants receiving physical activity. The effect of the 
same physical activity on bone turnover markers was examined by Moyer-Mileur (50) and 
Nemet et al (59) Both studies found an increase in bone formation markers; Moyer-Mileur 
found an increase in serum type one collagen c terminal peptide (PICP) in the exercise group 
compared to controls, both PICP and bone specific alkaline phosphatase were higher in the 
infants receiving physical activity in Nemet’s study. Moyer-Mileur found no difference 
between groups in urinary pyridoline cross links of collagen (PYD), a marker of bone 
resorption; however Nemet describes a reduction in another marker of bone resorption, ICTP, 
in the exercised infants. Aly et al used a combination of massage and a physical activity 
protocol in preterm infants established on full enteral feeds and this resulted in significantly 
higher serum PICP on hospital discharge compared to control infants (60). These studies using 
a physical activity programme were done when infants were on enteral feeds and receiving the 
recommended dietary intakes of minerals. If physical activity is given when mineral intake is 
limited it may not confer any benefit, and it is unknown whether it may even have a negative 
effect on bone mineralisation. A longitudinal study of physical activity in term infants found 
physical activity in the infants with low calcium intake resulted in lower bone mineral content 
than the control infants (61).  
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So, the optimum timing, frequency and duration of exercise remain unanswered questions. 
There are currently no studies which have reported on both the short and longer term effects of 
passive exercise (e.g. on neurodevelopment) in preterm infants. None of the studies on 
physical activity have reported on the incidence of fractures. 
 
Section 2 Assessment of neonatal bone health 
Current assessment of neonatal bone health 
The diagnosis of osteopenia of prematurity remains difficult, and there is a wide variation in 
practice reflecting the lack of evidence base.  Serum biochemistry may be normal or abnormal 
in the presence of bone disease and serum calcium and urinary phosphate excretion correlate 
poorly with bone mineralisation (62-65). Despite this, clinical practice commonly includes 
monitoring of serum biochemistry, primarily phosphate and alkaline phosphatase with low 
serum phosphate and high alkaline phosphatase suggestive of osteopenia of prematurity. Plain 
x-rays in the absence of fractures are poor at diagnosing bone disease due to the subjectiveness 
of the interpretation and the fact that changes are not seen until there is a significant reduction 
in mineralization (66).Most fractures are detected as incidental finding on x-rays taken for 
other reasons  
 
Other Means of Assessing Bone Health 
Dual energy X-ray absorptiometry (DXA), quantitative CT (QCT) and quantitative ultrasound 
are other available techniques to assess bone health. They currently function as research tools 
only for newborns and are not used in the routine investigation of osteopenia of prematurity. 
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Dual energy X-ray absorptiometry (DXA) 
DXA uses X-ray beams of 2 different energies which are projected on to bone and the 
absorption of each beam measured. Bone mineral content, bone area and average bone mineral 
density are calculated. Measurements can be made of both the axial and appendicular skeleton.  
DXA is considered the gold standard for diagnosis of osteoporosis in adults, with a T-score 
(standard deviation score) at any site of equal or less than 2.5 indicative of osteoporosis. DXA 
provides a 2D measurement of a 3D skeleton therefore BMD is influenced by bone size, and in 
the paediatric population size correction is required using height or weight. DXA results must 
be compared with normal data derived from healthy children of comparable age and maturity 
to calculate a standard deviation score. Although DXA is increasingly used to assess bone 
mineral status in newborn infants, the size and immobility of the scanner, the length of time to 
perform the scan and use of ionising radiation make it unsuitable for routine use in the setting 
of the fragile VLBW infant.  In addition, the data obtained from DXA can be difficult to 
interpret in newborns due to both movement artifact (67) and variations in technique (68). 
 
Quantitative computed tomography (QCT)  
QCT obtains cross-sectional images of bone and muscle using lower doses of radiation than 
standard computed tomography. It measures true volumetric bone density, bone and muscle 
geometry and can distinguish between cortical and trabecular bone. Images are most 
commonly obtained of the forearm (radius and ulna) and midshaft of the tibia. It is currently 
not possible to measure newborn infants using QCT as the equipment is not validated for such 
small limbs. Both axial QCT and peripheral quantitative computed tomography (pQCT) have 
similar limitations to DXA when considering their use on a neonatal unit.  
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Quantitative ultrasound 
Quantitative ultrasound (QUS) was first developed in 1984, as a non-ionising, portable and 
low cost method of assessing bone health. It measures attenuation of an ultrasound beam as it 
passes through a specified region of interest. Most commonly the broadband ultrasound 
attenuation (BUA, dB/MHz) or the speed of sound (SOS/VOS, m/s) are measured: some 
devices also measure bone transmission time (BTT). These measurements are thought not only 
to be related to the mineral density of the bone but also to reflect parameters of bone quality 
and strength (69;70).  
The majority of current ultrasound scanners are designed to transmit the ultrasound wave 
through the bone, a receiver measuring the attenuated wave at the other side. QUS may only 
be applied to the peripheral skeleton and sites for measurement are the calcaneus, phalanges, 
patella and tibia. The most commonly measured site is the calcaneus; it is rich in metabolically 
active trabecular bone, weight bearing and has little surrounding soft tissue, making it ideal for 
ultrasound measurements. The application of calcaneal ultrasound in children is difficult due 
to lack of a dedicated paediatric transducer. The DBM Sonic BP (IGEA, Italy), originally 
designed to measure adult phalanges, can be used to measure the phalanges or humerus of 
children and infants. It uses two probes, mounted coaxial on two separate branches of a 
calliper. The device measures the distance between the probes and the time elapsing between 
emission and reception to calculate the speed of sound. However, a more recently developed 
device (Sunlight Omnisense 2000P) is based upon just one probe being used, the ultrasonic 
wave travelling along the cortical bone and the reflected wave being measured, this technique 
is called ultrasound critical angle reflectometry. These newer devices, which measure at sites 
such as the phalanges, radius and tibia are more suitable for measurement in paediatrics and 
some devices have been specifically designed for children and neonates with age and 
gestational specific reference data.  
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From a technical point of view QUS has many advantages: it does not involve ionising 
radiation and it is easily accessible and transportable. There are now new devices with a 
dedicated hardware design and a well defined quality assurance/quality control procedure, the 
measurements are relatively fast, and the overall cost is low. 
QUS is reported to measure both qualitative bone properties, such as bone mineralization, and 
quantitative properties such as cortical thickness, elasticity and micro architecture (71-74). It is 
not yet possible to define more precisely what QUS measures. QUS measuring ‘bone strength’ 
is commonly used as a description, because of the association between higher QUS values and 
reduced fracture risk. In adults, QUS does not diagnose osteoporosis, but does (using calcaneal 
transverse transmission) predict clinical fractures independent of BMD (75;76). Although 
predictive of fractures in adults, QUS measurements in children and infants do not predict 
fractures. A recent study in adult women found tibial SOS correlated with site matched QCT 
and DXA (77).  Similarly, in children tibial ultrasonography has been found to correlate with 
bone mineral assessment by DXA (78). The impact of skeletal properties on QUS variables 
assessed by measuring the proximal phalanges using QUS (transverse transmission), QCT and 
MRI, found SOS was affected most by cortical area, cortical bone density and cortical porosity 
(79). In vitro studies of both newborns (gestational age 20-41 weeks) (80) and adults have 
shown forearm QUS correlates significantly with bone strength (81).  
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Figure 2.1 Schematic representation of the developing long bone. AC= Articular cartilage; 
EC= epiphyseal cartilage; 2o OC= secondary ossification centre; 2o OC GP = secondary 
ossification centre growth plate. Insert shows the cellular development of chondrocytes within 
the growth plate of the developing bone. 
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Figure 2.2 Principle of quantitative ultrasound in 
1.DBM Sonic and 2.Sunlight Omnisense.
The arrows show the direction of ultrasound waves. T is the transmitter, R is the receiver.
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Section 3 Maternal bone health and pregnancy 
Plasma calcium is maintained by a complex mechanism involving fluxes of calcium between 
the extracellular fluid and the kidney, bone and gut. Dietary calcium is absorbed form the 
small intestine, and this is mediated by 1,25 dihydroxyvitamin D. Calcium absorbed by the gut 
is then filtered by the kidney and the majority is reabsorbed in the proximal renal tubules, 
mainly under the control of PTH, which maximises tubular reabsorption of calcium. Usually 
bone mineral absorption equals skeletal mineral resorption i.e. calcium flow to and from bone 
should be neutral. Calcium release from bone is mediated by PTH in response to a low plasma 
calcium, and 1,25 dihydroxyvitamin D enhances this flux of calcium from bone when PTH 
increases.  
Mineralisation of the fetal skeleton places an increased demand on normal calcium 
homeostasis of the mother. Maternal intestinal calcium absorption increases early in gestation 
to double the normal pre –pregnancy state, largely mediated by increased 1,25 
dihydroxyvitamin D which increases the concentration of calbindin9k-D in the gut which binds 
calcium(82). In pregnancy the ionised calcium level remains steady, with a fall in total serum 
calcium and albumin. Serum phosphate levels are usually maintained in the normal range. The 
increase in vitamin D is independent of PTH, and is due to pregnancy induced renal changes, 
with a small contribution from the placenta and fetal kidneys (83). Renal hydroxylation is 
upregulated by factors such as PTH-related protein, oestradiol, prolactin and placental 
lactogen (84). 
Studies of bone biopsies during pregnancy (85) and also studies looking at bone turnover 
markers suggest that bone resorption increases during pregnancy, and that bone formation also 
increases after an initial decrease. Changes in the maternal skeleton during pregnancy have no 
consistent pattern, studies using DXA have reported an increase in total body BMC (86) and 
also a decrease in BMD (87). Quantitative ultrasound has advantages for use in pregnant 
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women and the newborn population as it is radiation free and portable. Recent studies using 
calcaneal quantitative ultrasound in the pregnant mother point to bone loss that is dependent 
on maternal lifestyle, fat stores and seasonality of early pregnancy (88). Two studies published 
in 2004 measured amplitude dependent speed of sound (AD-SOS) at the hand phalanges; 
Pluskiewicz et al (89) prospectively studied 48 pregnant women and found a decrease in 46% 
of study participants however there was no correlation between fetal growth or newborn size 
with changes in maternal AD-SOS. Tranquilli et al (90) found a similar significant reduction 
in AD-SOS in 50 women measured longitudinally across pregnancy. To date, radial SOS, 
measured by axial transmission, to assess changes in bone health during pregnancy has not 
been studied.  The effects of pregnancy therefore seem to have a wide inter-individual 
variation. Demographic and lifestyle factors are likely to exert some influence on these 
skeletal changes.  
The pregnancy induced changes seems to provide the calcium needs for the fetus with rarely 
any long term effects on the maternal skeleton. Osteoporosis of pregnancy is rare, women can 
present with fragility fractures with or without low bone mineral density. The condition 
usually involves the spine or hip, and resolves spontaneously a few months after the end of 
pregnancy. It may be that some of these cases are women who had pre-existing low BMD, in 
others fractures can result from increased bone resorption secondary to pregnancy or calcium 
or vitamin D deficiency.  
 
Section 4 Interaction between maternal and infant bone health 
Maternal effects on the skeleton of her offspring can be mediated by both genes and the in 
utero environment. The intrauterine environment has not only an immediate effect on neonatal 
bone health but also there is increasing evidence that this effect persists into infancy and 
childhood and can extend into adulthood. The rapid rate of mineral gain during intrauterine and 
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early postnatal life coupled with skeletal cell differentiation and replication is postulated to 
offer the possibility of unique interactions between the genome and the early environment 
which can enable a type of skeletal phenotypic or developmental plasticity (91) . This is a 
phenomenon by which one genotype can give rise to a range of different morphologies in 
response to different prevailing environmental conditions during development. This occurs 
during a critical time window and is then irreversible. The effect of these early developmental 
effects persisting into adulthood is known as programming (92). Three studies have described 
birthweight and postnatal growth as predictors of adult bone mass and skeletal size (93-95) and 
short birth length with slow childhood growth has been shown to predict adult hip fracture 
(96).  Maternal vitamin D status and nutrient intake has been described to have an effect on 
height, BMC, bone area and areal BMD in prepubertal children (97-100) 
 
Section 5  Vitamin D  
Vitamin D is vitally important for growth and maintenance of healthy bone. It is produced in 
the skin following exposure to sunlight, and in addition a small amount is produced from the 
diet. Vitamin D undergoes hydroxylation in the liver to 25 hydroxyvitamin D which is then 
further hydroxylated in the kidney to 1,25 dihydroxyvitamin D which is the active metabolite. 
This active metabolite acts on the gut to stimulate calcium and phosphate absorption. It acts to 
maintain calcium homeostasis, when dietary calcium is low calcium stores are mobilised from 
bone via PTH. Vitamin D status is usually assessed by measurement of 25(OH)D – which has 
two types, 25 hydroxyvitamin D2 and 25 hydroxyvitamin D3. Measurement of both together 
gives the best indicator of vitamin D status.  Vitamin D2 is provided by some dietary sources 
and multivitamins, and is less potent than Vitamin D3.  Vitamin D3 is the naturally occurring 
form in humans, is formed by action of ultraviolet light on vitamin D precursors in skin and is 
also present in some nutrients.   
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Vitamin D deficiency classically presents with rickets in childhood and osteomalacia in 
adulthood. Vitamin D deficiency is becoming increasingly reported (101-106). It is common in 
non caucasian individuals residing in countries with higher latitudes, and pregnant women and 
their children seem to be at particularly high risk. There are three factors which influence 
infant vitamin D status: vitamin D status at birth, vitamin D intake and exposure to sunlight. 
Exclusively breastfed infants of both caucasian and non caucasian origin are at an increased 
risk. A woman’s vitamin D status during pregnancy correlates with her child’s vitamin D status 
at birth, and babies born to mothers deficient in vitamin D are born with low stores.  A recent 
study of 50 mother-infant pairs showed that mothers deficient in vitamin D had babies 
deficient in vitamin D, and that these infants had, relative to birthweight, a lower whole body 
and femur bone mineral content measured by DXA (107). A well recognized cause of neonatal 
hypocalcaemia is maternal vitamin D deficiency. Clinical presentations include seizures and 
cardiomyopathy. Vitamin D deficiency in infants can have acute and long term sequelae which 
should be wholly preventable. Vitamin D has effects on immune function and muscle function 
as well as its effect on bone, as there are vitamin D receptors in lymphocytes, skin, brain, heart, 
stomach, pancreas and gonads. 
In one interventional study supplementing pregnant British Asian mothers with vitamin D 
resulted in a trend towards increased birthweight of offspring, with also higher weight and 
length at 1 year old (108). One recent study in the UK randomised pregnant women to receive 
vitamin D as a single oral dose of 200,000iu, a daily supplement of 800iu or no 
supplementation (109). The single or daily dosing both improved vitamin D levels significantly 
but only led to a small percentage of mothers and babies being vitamin D sufficient. Therefore 
further research is required to determine the optimal timing and dosing of vitamin D in 
pregnancy. Supplementation of infants who are exclusively breastfed is currently 
recommended by the UK government. There is currently one surveillance programme in the 
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UK to monitor the occurrence of rickets. This was recently started in Scotland and is co-
ordinated by the Scottish Paediatric Society (ScotPSU.) A positive effect persisting to 
adolescence was described by Zamora et al whose Vitamin D supplementation of Swiss infants 
resulted in higher prepubertal bone mass (110).  
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Chapter 3 Quantitative ultrasound assessment of neonatal bone health at birth –  
  cross-sectional study of term and preterm infants 
 
Introduction 
Preliminary studies suggest that the measurement of speed of sound (SOS) by quantitative 
ultrasound may be a useful adjunct for assessing bone health in infants (111;112). However, 
its methodology needs further exploration, especially in the sick, preterm infant. The current 
cross-sectional study was performed to assess the feasibility and reliability of the technique in 
this setting and to assess the relationship of SOS to the gestation and size of the infant. 
 
Subjects and Methods 
Study Population 
All babies born during the period December, 2002 – January, 2004, at three maternity units in 
Glasgow, were eligible for recruitment. Following LREC approval and informed written 
consent from parents, speed of sound was measured soon after birth, at a median age of 3 days 
(quartiles, 2, 5) in 110 infants (male, 60) with a median gestational age (GA) of 36 wks (range, 
24, 41) and median birthweight of 2565g (range, 680, 4600) (Table 3.1). The cohort, which 
included 5 sets of twins (4 of the same sex) was, arbitrarily, divided into three groups by 
gestation at birth, A (>37 wks), B (32-36 wks) and C (<32 wks).They were all clinically stable 
at the time of the scan (this included stable while ventilated for the extremely preterm infants) 
and without congenital malformations.  
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QUS Measurement 
SOS was measured using the Sunlight Omnisense 7000PTM scanner (Sunlight Medical, Israel). 
It is comprised of a main unit and a small hand held ultrasound probe. The OmnisenseTM 
generates pulsed acoustic waves, at a centre frequency of 1.25MHz (bandwidth 0.7 to 1.8). 
The probe contains two pairs of transducers; one acts as a transmitter and the other acts as a 
receiver. When ultrasound waves are incident on a subject such as bone, the waves are 
reflected, refracted or transmitted, depending on the angle of incidence. The refracted wave 
that propagates along the length of the bone can be measured. The time needed for the first 
detectable signal above noise to arrive at the receiving transducer is recorded. Because the 
transmitting and receiving transducers are at a fixed length, the length of the ultrasound 
pathway can be determined and, hence, the velocity can be calculated. A measurement 
consists of three scan cycles, each generating a representative SOS value. An internal 
algorithm checks the three SOS values for consistency and if the device detects any significant 
inconsistency, it instructs the user to obtain further measurements. An acoustic gel is used to 
couple the probe to the skin.  
SOS was measured at the radius and tibia. The site of measurement on the radius was 
determined by identifying the midpoint between the tip of the middle finger and the dorsal 
aspect of the flexed elbow (distal third of the radius) and the site of measurement on the tibia 
was determined by identifying the midpoint between the plantar aspect of the flexed foot and 
the dorsal aspect of the flexed knee (mid shaft of the tibia) (see diagram). The probe was 
aligned along and parallel to the bone and moved in a semi-arc over the circumference of the 
site of measurement until a reliable estimate of the SOS is measured. Each SOS measurement 
cycle took about 30 seconds and the result was expressed in metres per second (m/s), and 
displayed together with a Z score value (units of standard deviations relative to the age-
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matched population reference values) based on a reference range for term and preterm infants 
included with the software (113).  
 
Determining site of measurement of tibial SOS 
 
 
Validation studies were performed to assess (1) intraobserver variation – multiple 
measurements performed at one site (tibia) by the same observer in 15 infants, (2) 
interobserver variation – repeat measurements on two sites (left and right tibiae) in 6 infants, 
(3) variation between different sites in same infant – duplicate scans at each tibia and radius in 
20 infants, (4) effect of temperature and humidity on SOS – performed on adult subjects by 
placing arm in incubator and varying temperature and humidity.  
 
Statistical Analysis 
Using XL STAT V7.0 (Addinsoft, France) and Microsoft Excel 2000 (Microsoft Corp, USA), 
precision of the measurements was determined by calculating the coefficient of variation and 
differences between groups were compared using the Mann-Whitney U test. Analysis of 
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covariance was performed to assess any associations between variables. Due to the small size 
of the study twins were treated as independent variables. 
 
Results  
Intra-observer and Inter-observer variation 
The mean (1SD) intra-observer coefficient of variation (CV) for three repeat measurements at 
the tibia in 25 infants with a median GA of 37 wks (r, 33 - 41) was 1.2% (0.8%.) Each infant 
was measured and then the mark for that site of measurement was removed, and the infant 
repositioned between subsequent measurements. The technique precision error as calculated 
from the root-mean-square average of the CV was 1.4% (114). The mean interobserver CV for 
measurements performed by two observers at the tibia in 6 infants with a median GA of 26 
wks (r, 24 - 32) was 1.2% (0.7%).  
 
Inter-site variation 
In 20 infants with a median GA of 37 wks (r, 26 - 41) measurements were performed at both 
tibiae and radii. The mean CV (1SD) for measurements at all 4 sites was 2.4% (1.2%), left and 
right radius was 2.1% (1.4%), right radius and right tibia was 2.3% (1.8%), left radius and left 
tibia was 1.8% (1.2%), and left tibia and right tibia was 1.7% (1.8%.)  
 
Influence of Temperature and Humidity 
Radial SOS in 15 adults was measured at ambient temperature, 350C, and 350C with 95% 
humidity. The SOS did not change with increasing temperature and humidity. Mean CV (1SD) 
for all measurements was 2.0% (1.1%), measurements at room temperature and 35 degrees 
was 1.7% (1.1%), room temperature and 35 degrees with 95% humidity was 2.1% (1.8%), and 
35 degrees and 35 degrees plus 95% humidity was 1.7% (1.7%.)  
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Gestation and Birth Weight 
 
Median tibial SOS was 3079m/s (q, 3010, 3142,) in Grp A and significantly higher than in Grp 
B who had a median SOS of 2994m/s (q, 2917, 3043) or Grp C with a median SOS of 
2911m/s(q, 2816, 2982) (p<0.001) (Fig.3.1). There was no significant correlation between the 
birthweight and SOS in the infants in Grp A (Fig.3.2.) Analysis of covariance revealed that 
40% of the variability of tibial SOS was explained by gestation, birthweight and gender 
(p<0.001) and gestation had the greatest impact, followed by birthweight, and then gender.  
 
Influence of Size 
In Grp A and B, there were no significant differences between the tibial SOS for the SGA and 
AGA infants. However, in Grp C, tibial SOS was greater in the two SGA than the AGA 
infants (SOS values 3011 and 3056) and median SOS 2909m/s (q, 2790, 2997) respectively 
(p<0.05). In the 5 sets of twins, tibial SOS tended to be higher in the lighter twin (Fig.3.2).  
There were no significant differences between the LGA and AGA infants.  
 
Discussion 
Not only does this study reinforce the finding of previous studies that quantitative ultrasound 
assessment of SOS can be performed successfully and precisely in infants from 24 weeks 
gestation through to term (112;113), it also shows that, at this age, the assessment is not site-
specific, and measurements at one tibial site are sufficiently representative of the SOS at the 
other sites in the neonate.  The validation studies also confirmed that the changes in 
temperature and humidity that are often encountered in an intensive care neonatal unit do not 
seem to alter the reproducibility of the measurements performed. 
Unlike most previous studies, the infants in the current study were measured very shortly after 
birth, eliminating the confounding effect of the associated co morbidities that are often 
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encountered in the preterm infant (111;112). The close correlation of tibial SOS with 
gestational age rather than birth weight, agrees with other recent reports where measurements 
were performed within the first 4 days, suggesting that maturity may be a more important 
factor in bone health than birth weight (113;115). The relative lack of an association between 
birthweight and speed of sound was reinforced, firstly, by the findings in the SGA infants who 
did not have a lower tibial SOS than gestation-matched AGA infants, and secondly by the 
twin-studies where the tibial SOS was similar, and even slightly higher in the growth retarded 
twin.  
A weakness of this study was that twins were included as independent variables. In the general 
population of preterm infants twins are over represented and in our small sample size the 
pragmatic approach of including both twins was taken. It would have been better to recruit 
only one of each twin pair. However, for clarity, we have presented raw data on graphs clearly 
identifying twins, rather than condensing data into groups.  
The future application of quantitative ultrasound in assessing the bone health of infants 
deserves further exploration and the data in this report shall prove beneficial in designing 
longitudinal studies. 
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Table 3.1 
 
 
 >37 wks 32- 36 wks <32 wks 
Number of infants 62 28 20 
Median gestation (wks) 
(25th,75th centiles) 
40 
(38, 41) 
33 
(32, 34) 
28 
(26, 30) 
 
Male:Female  
37:25 14:14 9:11 
Median birth wt (g) 
(25th, 75th centiles) 
3490 
(3075, 3788) 
1890 
(1590, 2310) 
1080 
(920, 1280) 
 
SGA1 
AGA2 
LGA3 
4 
49 
9 
9 
17 
2 
2 
17 
1 
 
Caucasian 
Asian 
Mixed race 
57 
4 
1 
28 
0 
0 
18 
1 
1 
 
History of PROM 1 1 1 
 
Antenatal steroids 
 
Twins 
0 
 
0 
10 
 
8 
8 
 
2 
 
Oligohydramnios 1 3 0 
 
SVD 
Caesarian Section 
Forceps 
Vaginal breech 
34 
16 
11 
1 
10 
13 
3 
2 
10 
8 
1 
1 
 
Breast  
Formula 
Breast and formula 
TPN (+/- enteral feeds) 
 
27 
23 
12 
0 
 
8 
8 
9 
11 
 
1 
1 
3 
19 
 
 
Table 3.1 Details of infants undergoing SOS measurement.  
The cohort is divided into 3 groups according to gestation, those born at >37 weeks, those 
born between 32 and 36 weeks, and those born at <32 weeks. 1 SGA - small for gestational 
age, on or below the 9th centile for weight. 2 AGA - appropriate for gestational age, between 
10th and 90th centile for weight. 3 LGA - large for gestational age, above 90th centile for 
weight. 4 PROM - prolonged rupture of membranes. 5 SVD - spontaneous vertex delivery. 
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The closed circles represent speed of sound (SOS) values in infants appropriate for gestational 
age (AGA), birthweight between the 10th and 90th centile for weight. The open circles 
represent SOS values in small for gestational age infants (SGA), birthweight on or below the 
9th centile for weight. 
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The closed circles represent speed of sound (SOS) values in singleton infants. The other 
symbols represent SOS values in twin pairs. 
Note that 4 twin pairs were of discordant growth at birth (one twin small for gestational age 
(SGA), on or below the 9th centile for birthweight and the other twin appropriately grown for 
gestational age (AGA), between the 10th and 90th centiles for birthweight). 
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Chapter 4 Quantitative ultrasound assessment of neonatal bone health from  
  birth to 2 years in preterm infants 
 
Section 1 Longitudinal evaluation of bone health as assessed by QUS in preterm 
  infants from birth to term CGA 
Introduction 
Preliminary studies by our group suggest that the technique of quantitative ultrasound is a 
feasible and accurate method of assessing changes in bone health in preterm infants.  We 
hypothesize that the neonatal course has an effect on bone development. In this study we 
performed serial measurements in a cohort of VLBW infants from birth to discharge and 
investigated the relationship between traditional markers of OP, markers of clinical illness and 
SOS. 
Patients and Methods 
 
Study Population 
Between December 2002 and January 2004, infants who were less than 32 weeks gestation 
and less than 1500g birth weight were recruited from three neonatal units in Glasgow, UK. 
The study was approved by the Local Research Ethics Committee at all three maternity 
hospitals. Twenty five eligible infants with a median gestation of 27 weeks (range 24-31 
weeks) and median birthweight of 980g (range 625-1500g) were recruited into the study 
following informed consent from their parents. Twenty three infants had an initial tibial 
ultrasound scan in the first week of life (one infant was too unwell, and in one case the scanner 
was out of order.) Eighteen of the twenty three infants had at least five serial scans until a 
median gestational age of 36 weeks (range 35, 37) (three infants died and two were discharged 
very early.) Routine clinical and anthropometric data, including details of nutrition, respiratory 
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complications and serum biochemistry were collected in these infants. Weekly measurements 
were performed until term corrected age or until the infant was discharged home. Details of 
the eighteen infants followed longitudinally are presented in Table 4.1. No infant sustained a 
clinically evident fracture during the study period. 
The CRIB (Clinical Risk Index for Babies) score is a validated tool for assessing initial 
neonatal risk and severity of illness of the preterm infant with higher scores being associated 
with increasing mortality and morbidity (116). It is based on birthweight, gestational age, 
minimum and maximum oxygen requirement and base excess in the first 12 hours of life, and 
presence of congenital abnormalities. More recently, temperature at admission has been added 
to this to provide a new score(117). 
 
Speed of Sound Measurement 
SOS was measured at the tibia using the Sunlight Omnisense 7000PTM scanner (Sunlight 
Medical, Israel) as described in the previous chapter. Ultrasound measurement was not 
performed if the infant was felt to be too unstable or if access to the tibia was difficult, for 
example, due to intravenous cannulation. Measurements were made by one of two operators. 
 
Statistical Analysis 
The data were expressed as medians and percentiles which were compared using the Mann-
Whitney U test. Spearman rank correlations were used to compare any association between 
variables and analysis of covariance (ANCOVA) was performed to establish the level of 
associations between multiple measured variables. Statistical analysis was performed with XL 
STAT V7.0 (Addinsoft, France) and Microsoft Excel 2000 (Microsoft Corp, Redmond, WA, 
USA). 
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Results 
Initial scan 
In the 23 infants who had an initial scan, the median age at first scan was 4 days (range 1, 7.) 
The median SOS was 2923m/s (2672, 3107). There was a strong correlation between SOS and 
gestation (r, 0.8, p<0.005.) Conversion of the SOS data to SDS was performed to separately 
evaluate the association of SOS to birth weight and gestation. Median SDS z score was 0 (–
1.3, 1.3.) The correlation of SOS SDS to birthweight was lower (r, 0.4, NS) compared to that 
for absolute SOS to birthweight (r, 0.6, p<0.05) indicating only a small effect of birthweight 
independent of gestation. 
 
Serial Scans 
A fall in SOS was noticed in all eighteen infants who had serial scans (Fig.4.1). The median 
fall in SOS from first to last scan was 95m/s (28, 289). The median SOS initially and at the 
end of the study was 2923m/s (2672, 3107) and 2802m/s (2502, 2991) respectively p<0.05 .   
The median Z score at the start and end of the study was 0 (–1.3, 0.55), and –2.15 (-0.45, -4.5). 
Expressed as a Z score, this fall was greater in the 24 - 27 weeks gestation cohort with a 
median reduction of 2.2 SDS (1.6–4.0) compared to a median reduction of 1.3 SDS (0.85-2.2) 
in the 28-32 weeks cohort (p<0.05).  
 
Alkaline phosphatase 
Peak serum total alkaline phosphatase (ALP) was reached by all infants at a median corrected 
age of 33 weeks gestation, and measured 741 iu/l (251, 2199.) In five infants serum ALP was 
within the normal reference range throughout the study period. Peak serum ALP was 
negatively correlated with tibial SOS at the end of the study (r, 0.6, p<0.05 (Fig 4.2) 
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Three infants in the study had a combination of high alkaline phosphatase (859, 1094, 2199 
u/l) and low serum phosphate (<1.2mmol/l) suggestive of OP.  These infants had the lowest Z 
scores (-4.5, -3.6, -4) and the lowest absolute speed of sound of any infant in the study (2502, 
2508, 2532 m/s). A further six infants also had Z score <-2.0, four out of these six had a raised 
serum ALP with a normal phosphate, and two had both a normal serum ALP and phosphate. 
(Table 4.2) 
 
Severity of illness 
Of the infants who had serial scans the median CRIB and CRIB II scores were 2 (0-9) and 10 
(5-14) respectively. There was a negative correlation between SOS at the end of the study and 
CRIB and CRIB II scores (r, 0.6 and 0.6 respectively, p<0.01) (Fig 4.3.) 
There was no significant difference in SOS at the end of the study in infants with or without 
chronic lung disease. Two infants (both born at 25 weeks gestation) developed necrotising 
enterocolitis, these were two of the three infants with the lowest absolute SOS and 
biochemical evidence of OP.  
 
Nutrition 
All infants initially required infusion of total parenteral nutrition (TPN.) The median number 
of weeks to full enteral feeds was 3 (1, 17.) Out of the 18 infants, 11 required TPN for more 
than 3 weeks. The median tibial SOS at the end of the study for these 11 infants and the 
remaining 7 infants were 2746m/s (2502-2866) and 2842m/s (2778-2991) respectively 
(p<0.05, Fig.4.4.)  
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Growth 
During the period of serial scans the median average weekly weight gain was 116g (range 100 
– 191.7g.) There was no correlation between average weekly weight gain and either gestation 
(r, 0.07) or fall in SOS SDS (r, 0.27.) 
 
Analysis of covariance 
Gestation was the most significant variable in relation to SOS at 35-37 weeks when ANCOVA 
was performed in 3 combinations using gestation, gender, CRIB score, birthweight, alkaline 
phosphatase, age to full feeds, and chronic lung disease. (Table 4.3) 
 
Discussion 
In this study we have looked prospectively at changes in tibial SOS in 18 very low birth weight 
infants. The initial SOS for all infants was in the expected range, suggesting that all the infants 
had undergone skeletal development until the point of preterm birth. However, on longitudinal 
follow up the SOS fell rather than increasing as would be expected based on our cross-
sectional reference data (118). The fall in SOS occurred in all infants but was greatest in those 
infants born earlier than 26 weeks gestation. Infants who were the most significantly unwell 
and predicted to have a greater risk of morbidity, as assessed by the CRIB and CRIB II scores, 
had the lower SOS scores at 35-37 weeks PCA. This emphasizes that even with advances in 
neonatal nutritional care, which has primarily concentrated on improving bone mineral 
accretion, the exutero environment remains a poor substitute for the in utero development. 
Both mineral deficiency causing decreased bone synthesis or lack of mechanical stimulation 
causing increased bone resorption could contribute to abnormal skeletal development in our 
preterm infants.   
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SOS fell despite adequate nutrition resulting in sustained weight gain. This might reflect an 
exacerbation of relative mineral deficiency by the demands of growth. Interestingly the 
presence of chronic lung disease did not have a significant effect on the fall of SOS. 
 
Nemet et al (111) assessed tibial SOS in preterm infants at a median post-natal age of 4 weeks 
( range 1-18 weeks ) and found the SOS correlated with gestational age, with preterm infants at 
term corrected age having a significantly lower SOS than term control infants. There was a 
significant inverse correlation of SOS with serum alkaline phosphatase in the preterm group. 
We also found an inverse correlation between tibial SOS at the end of the study and peak 
alkaline phosphatase. The three infants with the lowest SOS values had low serum phosphate 
as well as high alkaline phosphatase. However, all the infants in our study had a fall in SOS, 
even those with a serum ALP in the normal range. If a reduction in SOS indicates bone disease 
this would question the role of alkaline phosphatase as a screening test for OP.  It should also 
be borne in mind that serum ALP is the sum of three isoforms (liver, intestine and bone) and 
some of the changes may reflect disorder of liver function. However, the bone isoform 
contributes to the largest proportion of ALP in infants and children and changes in that isoform 
generally mirror those in total serum ALP (108). Bone specific ALP in the neonate has not 
been found to improve sensitivity for OP (62). 
It is well established that fractures do still occur in VLBW babies. Amir et al reported fractures 
in 1.2% of preterm infants between day 24-day 160 (28), Dabezies found a fracture rate of 
10.5% diagnosed at a mean age of 50 days (29). The fall in SOS noted in our patients at 35-37 
weeks might suggest an abnormality of bone strength which would correlate with an increased 
risk period for fractures. 
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Passive exercises might be of benefit in increasing bone strength. Two separate studies have 
demonstrated a positive effect using range of motion exercise interventions. The same exercise 
protocol consisting of daily flexion against passive resistance at the wrist, elbow, shoulder, 
knee and hip resulted in increased bone mineral density (determined by single-photon 
absorptiometry and DXA)(57) and an attenuation of the decrease in SOS postnatally in preterm 
infants (58) compared to controls. Moyeur-Mileur (57) also found an increase in body weight 
gain, forearm bone length, bone area and fat free mass in the exercise group. 
 
In conclusion, very low birth weight infants show a fall in postnatal tibial SOS and by term the 
SOS is well below that of infants born at matched gestation suggesting there may have been an 
arrest in bone development. Gestation at birth is the most important influential factor, and the 
fall in SOS was greatest in the 24-27 week gestation cohort. The association of SOS with 
serum ALP, phosphate, as well as markers of illness severity suggests that routine 
measurement of SOS may have a place in non-invasive monitoring of bone health of the 
preterm infant. 
 
 59 
Section 2 Changes in quantitative ultrasound in infants born at less than 32  
  weeks gestation over the first 2 years of life 
 
Introduction 
Studies by our group and others show reduced SOS as measured by QUS during the 
immediate neonatal period (112;115;119) however there is a scarcity of data on SOS changes 
following hospital discharge. Fractures are reported to occur most often around term CGA 
(which frequently coincides with discharge from the neonatal unit) and rarely after 6 months 
CGA (120). Most preterm infants who are small for their CGA at hospital discharge attain an 
appropriate weight and length (compared to term infants of the same post menstrual age) over 
the first year of life through a period of catch up growth. It is our hypothesis that tibial SOS 
increases over the first two years of life and that the rate of increase would be determined by 
the infant’s neonatal course. Therefore the aim of this study was to assess bone health, 
including assessment of SOS from term to 2 years post term corrected age in infants born 
prematurely. 
 
Materials and Methods 
Study Population 
Infants born at less than 32 weeks gestation were recruited from a neonatal follow up clinic in 
the Queen Mother’s Hospital, a tertiary centre in Glasgow, between February 2004 and April 
2005. The study was approved by the local ethics committee, and informed written consent 
was obtained from parents prior to their child being included in the study. Infants were eligible 
for inclusion if born before 32 completed weeks of gestation, and exclusion criteria were the 
presence of congenital abnormalities, as well as any congenital skeletal deformity. Details of 
the child’s neonatal history and current feeding were recorded from the case notes, and weight 
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and total body length were measured at the clinic visit using Avery baby scales (accurate to 
10g) and Holtain supine length measuring table (accurate to 200mm) respectively. Weight and 
length were converted to standard deviation scores  (SDS) which are units of standard 
deviations relative to the mean for an age and sex matched population reference values. 
Corrected gestational age (CGA) was calculated for all infants, based on an age of 0 days at 
the 40 week post menstrual date. The number of days each infant received total parenteral 
nutrition (during their neonatal inpatient admission) was recorded from the case notes. All 
infants except one received oral phosphate supplementation once established on enteral feeds 
on the neonatal unit. All infants except one received vitamin D 400 IU daily once established 
on enteral feeds until 1 year corrected age. Six infants received diuretics (4 had furosemide 
and spironolactone, 1 had chorthiazide and spironolactone and 1 had spironolactone only) and 
one infant received postnatal dexamethasone. Chronic lung disease was defined as a 
requirement for oxygen at 36 weeks corrected gestational age (CGA.) The CRIB (Clinical 
Risk Index for Babies) score was used as a tool for assessing severity of illness of the preterm 
infant (116). Thirty nine infants were recruited, generating cross-sectional data.  One infant 
was excluded from further analysis as the case notes could not be obtained. Fifteen of these 39 
infants had serial measurements of SOS, generating longitudinal data. Eight of the fifteen had 
measurements at term CGA and early infancy (early group) and seven had serial 
measurements performed in later infancy (late group.) Details of these infants are outlined in 
Table 4.4. 
 
Speed of Sound Measurement 
SOS was measured by two operators at the tibia using the Sunlight Omnisense 7000PTM 
scanner (Sunlight Medical, Israel) as described previously. The result was expressed in metres 
per second (m/s), and displayed together with a Z score based on a cross-sectional reference 
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range for term and preterm infants provided by the manufacturers (113;121). Two different 
probes were used, the CS and CM probe, and it should be noted that the manufacturer’s 
reference range is slightly different for each probe.  For consistency, all measurements until 
term were made using the CS probe, all measurements made post term corrected age were 
made using the CM probe. SOS SDS rather than absolute SOS values was used in analysis of 
longitudinal change, and also for correlation with variables such as serum biochemistry. This 
was to minimise the potentially confounding effect of the two different probes. 
 
Serum Biochemistry 
Peak total serum alkaline phosphatase (ALP, IU/l) measured, between 35-37 weeks corrected 
gestational age (CGA) was recorded. Lowest serum phosphate (PO4, mmol/l) measured 
between 35-37 weeks CGA was also recorded. A conjugated hyperbilirubinaemia was 
recorded as present if the conjugated bilirubin was >10% of the total measured bilirubin 
during the neonatal inpatient stay (mmol/l). 
 
Statistical Analysis 
 
The data were expressed as medians and ranges. Qualitative variables were compared using 
the Mann-Whitney U Test. Pearson’s correlation coefficients were used to compare any 
association between quantitative variables. P values <0.05 were taken as significant. Statistical 
analysis was performed with Minitab v.12.21 (Minitab Inc.) 
 
 
 
Results 
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Cross-sectional Data 
Thirty-nine infants were divided into 3 subgroups by age (CGA) at SOS measurement: 0-6 
months, 6-12 months and >12 months. The characteristics of these infants and the 
relationships between qualitative and quantitative variables are reported in Table 4.4 and 
Table 4.5.   
In the group as a whole there was a strong positive correlation between SOS and corrected 
gestational age, r=0.8, p<0.005 (Figure 4.5.) The youngest infants, 0-6 months CGA 
demonstrated a significant negative correlation between SOS SDS and TPN duration, (r -0.7, 
p<0.005) as well as a significantly lower SOS SDS for the 7 of 15 infants who required TPN 
for more than 14 days versus those who had TPN for less than 14 days, median SOS SDS -1.6 
and -0.6 respectively, p<0.05. In this subgroup there was also a significant positive correlation 
between SOS SDS and neonatal serum phosphate (r 0.6, p<0.05). These correlations were not 
significant in the older children, or in the study group as a whole. In the infants age 0-6 
months CGA CRIB score was negatively correlated with SOS SDS, r -0.6 but this was not 
statistically significant. There were 18 infants with CLD in our study group, and there was no 
significant difference in SOS SDS for those with or without CLD. Age at independent walking 
which was available in 17 patients was reported as a median of 17 months CGA (range, 10.5, 
20.) There was no relationship between age at walking and SOS SDS, r=0.014, NS. Type of 
feeding was available in 30 infants, 6 received post discharge formula which was calcium and 
phosphate enriched, median SOS SDS for these 6 infants was -0.6 (range, -2.5, 2.1) compared 
to median SOS SDS of 0.13 (range, -3.55, 2.3) for the 24 infants discharged breastfeeding or 
on standard formula (ns.) The infants who received post discharge formulae were likely to be 
smaller and sicker. 
 
Early Longitudinal Data  
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Seven infants (5 female) had at least two SOS measurements. Tables 4.6 shows the 
characteristics of these infants. All 7 had SOS measured around term CGA (36-40 weeks) and 
subsequently at a median age of 5 weeks CGA (range, 5 - 55) (Figure 4.5,  absolute SOS 
values illustrated) Five of the 7 infants had a third measurement at a median age of 45 weeks 
(range, 15-80) which was a median of 27 weeks after 2nd measurement (range, 10-76.) In 6 of 
the 7 infants SOS SDS showed an increase between measurements. In 1 infant, although 
absolute SOS increased, SOS SDS continued to decrease post term until 6 weeks CGA then 
began to increase. This infant had the longest duration of TPN amongst the study cohort (120 
days.) SOS SDS was low at term CGA, with a median of -2.2 (range, -3.6 to -0.5) and 
increased to a median of -1.5 (range, -4.1 to 0.8) by 2nd measurement, and median of 1.0 
(range, -0.7 to 2.6) by third measurement. Median SOS SDS significantly increased from -2.2 
(range, -3.6 to -0.5) to 0 (range, -1.7, 1.8) (p<0.005) between first (term corrected age) and 
final measurements (median age of 0.7 years, range, 0.1, 1.1.)  
The median change in SOS between first and last measurements was 443m/s (range, 144-640) 
with a median change of 10.9 m/s per week (range, 5.4 – 15.1.) The babies with the lowest 
SOS at term had the greatest increase in SOS over time (r 0.9, p=0.008.) Figure 4.6.  There 
was no correlation between change in weight SDS or length SDS and change in SOS SDS, r -
0.3 and -0.9, NS. 
 
Late Longitudinal Data  
Eight infants had SOS measured twice over the age range 11 weeks to 2 years CGA. The 
characteristics of this group are shown in Table 4.6. Median age at first measurement was 33 
weeks CGA (range, 11-88) and at second measurement was 65 weeks (range, 18-103.) Median 
SOS SDS was 0.55 (range, -1.75 to 2.3) and 1.2 (range, -0.9 to 2.5) at first and second 
measurements (NS.) The median time between measurements was 17.5 weeks (range, 7-71) 
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and the median change in SOS SDS was 0.2 (range, -0.15 – 2.5.) The median change in SOS 
per week was 7.2 m/s (range, 1.2-8.45.) 
Median weight SDS was -0.99 (range, - 2.56 to 0.96) and did not significantly change over 
time. Median length SDS was -0.15 (range, -1.33 – 2.11) and -0.64 (range, -1.87, 1.13) at first 
and second measurements (NS.) There was no correlation between change in length and 
change in SOS SDS score, r= -0.01 NS. 
The characteristics of infants followed longitudinally did not differ significantly from the 
infants who were only included in the cross sectional results. 
 
Discussion 
Our cross-sectional data show that in most, but not all infants SOS was within the 
manufacturer’s reference range which is based on children born at term. This is interesting as 
published studies (119;122;123) show SOS to plateau or decrease in preterm infants during the 
period from birth to discharge. Therefore, there has been catch up in SOS, which parallels the 
catch-up in BMC measured by SPA and DXA reported in some studies (37-43).  
One of the critical aetiological factors in osteopenia of prematurity is inadequate phosphate. It 
is therefore not surprising that there was a significant correlation between serum phosphate 
and SOS SDS score in the infants age 0-6 months. Indeed, Kurl et al (124)  reported 
hypophosphataemia at 6 weeks of age to be associated with a 7.8 fold risk of having low BMC 
later in infancy. Backstrom also showed low serum phosphate at 3 weeks to be negatively 
associated with a change in BMAD between 3- 6 months of age in ex preterm infants (62). 
Our previous data showed a negative relationship between duration of TPN and SOS SDS at 
term (119), and TPN duration also had a significant effect on SOS SDS in study infants aged 
0-6 months. CRIB score, conjugated hyperbilirubinaemia, elevated ALP and IUGR were not 
significant factors. This may be because the number of infants was too small, however 
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Backstrom et al (62) also found there to be no significant difference in forearm BMAD 
(measured by DXA) at 6 months CGA in preterm infants with complications in the neonatal 
period as compared to the non-complicated group, whereas at 3 months CGA there had been a 
difference in BMAD between the two groups. Only one infant older than 6 months CGA had a 
low SOS SDS score (-2.5 at 20 months CGA.) This infant was IUGR at birth, growing 
between 2nd and 10th centiles at time of measurement, and did not have a low serum 
phosphate, raised alkaline phosphatase or conjugated hyperbilirubinaemia in the neonatal 
period. She did not have chronic lung disease, however her mother was a heavy smoker during 
pregnancy. 
 
The significant effect of neonatal factors in infants at 0-6 months which then disappears in the 
older infants, coupled with the rapid increase in SOS from term to 6 months in the early 
longitudinal group points towards an early window when catch-up occurs. This pattern has 
similarities with SGA infants who have an early period of catch up growth (125). However, we 
found no significant effect of weight or length gain on SOS SDS. According to the 
manufacturer’s reference range (based on cross-sectional measurements), in-utero SOS 
increases steadily from a mean of 2850m/s to 3100m/s between 26 and 40 weeks gestation,  
this equates to an increase in SOS of 15.7m/s per week. The infants in our early longitudinal 
group gained 10.9m/s per week post term. This raises the possibility of an internal biostat 
which is switched off in preterm infants after birth, and which when it restarts works closer to 
the higher in-utero rate of accretion until catch up is achieved. This may explain why the 
greatest gains over the first 6 months were seen in those with the lowest speed of sound at 
term. A similar trend in bone mineral accretion with a rapid phase of increase starting at 40 
weeks PCA has been previously described (38;39).  
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A significant weakness in this study is the use of two different probes, each with a different 
reference range. Although the larger probe (CM) is set up by the manufacturers to be used at 
term corrected age (immediately following use of the CS probe designed for preterm infants) 
the reference ranges do not merge perfectly. This raises the question of minor errors in the 
manufacturer’s reference ranges and indicates that a study comparing both probes in babies 
aged between 36 to 42 weeks CGA is needed.  Because the reference range for the CM probe 
is slightly lower, the duration of time to ‘catch up’ may actually be longer than suggested by 
our data. Following hospital discharge increased handling and movement may be important in 
determining the timing and extent of recovery in the SOS. Passive exercise has been shown to 
attenuate the decrease in SOS from birth in a small group of preterm infants (58). Lower 
physical activity levels, with a concomitant decrease in bone loading have been suggested as a 
potential cause of long term bone deficiency in infants born prematurely (47;126). It is 
possible that those infants who are slow to catch up do have an increased risk of fractures 
during the period of time that SOS is low. Our finding of SOS reaching the normal range in 
the majority of ex preterm by 6 months would fit in with the observation of Koo who did not 
observe fractures or radiological rickets in ex VLBW babies after 26 weeks postnatal 
age(120).   
 Although the relative size of the population sample restricts the power of this study, our 
observation that the window of recovery in bone SOS maybe restricted to the first 6 months 
following discharge is novel. Greater numbers of study infants are needed to confirm this 
finding as the numbers are too small for definite conclusions to be made. Although after 
discharge, feeding with enriched formula may confer  additional benefit in bone mineralisation 
or growth compared to standard term formula (127), future studies should, nevertheless, study 
carefully any link between feeding regimens and recovery in bone health. 
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In summary, we have observed a period of catch up in bone SOS in preterm infants that may 
be limited to the first 6 months following hospital discharge. Interventions that are aimed at 
improving bone health in these infants need to consider this period of spontaneous 
improvement in bone health. 
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Table 4.1 
 
 
No of infants 18 
Male: Female 7:11 
Gestation (weeks) 27 (24,32) 
Birthweight (g) 957 (625, 1500) 
SGA1 
AGA2 
LGA3 
4 
14 
0 
Initial SOS (m/s) 2923 (2672, 3107) 
SOS at 35-37 wks PCA4 (m/s) 2802 (2502, 2991) 
CRIB score  2 (0,9) 
CRIB 2 score  10 (5,14) 
Peak alkaline phosphatase (iu/l) 741 (251,2199) 
Age at full enteral feeds (days) 24 (6,120) 
No of infants ventilated 13 
No of infants with chronic lung disease5 9 
Twin pregnancy 5 
No of infants with radiologically proven 
NEC6 
2 
 
Table 4.1 – Characteristics of infants who had serial ultrasound scans. 
All values are medians (ranges) 1- SGA, small for gestational age, birthweight below 10th 
centile for gestation on a standard UK growth chart. 2 - AGA, appropriate for gestational age, 
birthweight >10th and <90th centiles for gestation on a standard UK growth chart. 3 - LGA, 
large for gestational age, birthweight above the 90th centile for gestation on a standard UK 
growth chart. 4 – PCA, postconceptional age, number of weeks postconception. 5 – CLD, 
chronic lung disease, a requirement for supplemental oxygen at 36 weeks PCA. 6 – NEC, 
radiologically proven necrotising enterocolitis. 
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Table 4.2 
 High ALP1 Normal ALP1 
 SOS> 2SDS2 SOS<2SDS3 SOS>2SDS2 SOS<2SDS3 
Low phosphate4 0 3 0 0 
Normal phosphate4 4 4 4 2 
 
Table 4.2 – Serum alkaline phosphatase (ALP) and serum phosphate in seventeen study 
infants (one infant had no serum phosphate or alkaline phosphatase measured) categorised 
according to speed of sound (SOS) SDS.  
1 - ALP was defined as high and normal by a level above or below 420iu/l, respectively. 2 – 
SOS>2 SDS, speed of sound measurement within 2 standard deviation scores of the mean for 
an age and sex matched population. 3 – SOS<2 SDS, speed of sound measurement more than 
2 standard deviation scores below the mean for an age and sex matched population. 4 – 
phosphate was defined as low or normal defined on serum phosphate level below or above 1.2 
mmol/l, respectively. 
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Table 4.3 
 Variables Goodness of fit 
coefficient, R 
Type 1 SS 
Pr>F  
Gestation 0.001 
Birth weight 0.742 
CRIB1 0.057 
ANCOVA 1 
Sex 
0.8 
0.654 
Gestation 0.000 
Serum ALP2 0.116 
Age at full feeds 0.465 
ANCOVA 2 
Sex 
0.8 
0.261 
Gestation 0.001 
CRIB 0.116 
Age at full feeds 0.465 
ANCOVA 3 
CLD3 
0.8 
0.261 
 
Table 4.3 – Analysis of covariance of variables in relation to speed of sound at the end of the 
study.  
1 – CRIB, clinical risk index for babies. 2 – serum ALP, serum total alkaline phosphatase. 3 – 
CLD, chronic lung disease, a requirement for supplemental oxygen at 36 weeks post 
conceptual age. 
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Table 4.4 
 
0-6 months  
 (n=15) 
6-12 months  
(n=10) 
12+ months  
(n=13) 
Study group (n=38) Quantitative 
Variables 
Median 
(range) 
R valuea 
(p value) 
Median 
(range) 
Rvalue 
(p value) 
Median 
(range) 
R value 
(p value) 
Median 
(range) 
R value 
(p value) 
Gestation (wks) 
b
 
27 
(26,31) 
 27.5  
(24, 31) 
 31  
(27, 31) 
 28.5  
(24, 32) 
 
Age at scan 
(wks post term 
corrected) c 
11  
(2, 26) 
 35.5  
(28, 52) 
 73  
(54,104) 
 34  
(2, 104) 
 
SOS (m/s) d 2942 
(2609, 
3064) 
 3269 
(3009, 
3413) 
 3327 
(3110, 
3495) 
 3203 
(2609, 
3495) 
 
SOS SDSe -1.5  
(-4, 1) 
 1.6  
(-
0.6,2.4) 
 0.2  
(-2.5, 
3.5) 
 -0.6  
(-4, 3.5) 
 
Birthweight  (g) 
f
 
1010 
(625, 
1810) 
-0.1  
(ns) 
1138 
(740, 
2250) 
0.2  
(ns) 
980 
(845, 
1600) 
0.4 
 (ns) 
1090 
(625, 
1430) 
 
Weight SDSe -1.5  
(-
2.6,2.1) 
0.3 
 (ns) 
-0.9  
(-
1.9,1.1) 
0.5  
(ns) 
-0.5  
(-2.7, 1) 
-0.2  
(ns) 
-1  
(-
2.6,2.1) 
-0.1  
(ns) 
Length SDSe -0.6  
(-
3.3,2.1) 
0.1  
(ns) 
0.3  
(-
1.9,2.6) 
0.1  
(ns) 
-0.4  
(-4.2, 
1.5) 
0.0  
(ns) 
-0.3  
(-
4.2,2.6) 
-0.2  
(ns) 
CRIB scoreg 2  
(1, 9) 
-0.6 
(ns) 
1  
(1, 7) 
-0.2  
(ns) 
2  
(0, 10) 
-0.1  
(ns) 
2  
(1, 10) 
-0.2 
 (ns) 
Phosphate 
(mmol/l) h 
1.4   
(0.9, 1.8) 
0.6 
(<0.05) 
1.2  
(0.8, 1.8) 
-0.1  
(ns) 
1.5  
(0.8,2.3) 
0.2  
(ns) 
1.4  
(0.8, 2.4) 
0.1 
(ns) 
TPN duration 
(days) i 
14  
(5, 120) 
-0.7 
(<0.005) 
10 
(4, 95) 
-0.1 
(ns) 
10  
(5, 42) 
0.2  
(ns) 
13  
(5, 120) 
-0.2  
(ns) 
ALP (u/l) j 376  
(163, 
1094) 
-0.5  
(ns) 
678  
(175, 
1287) 
0.2  
(ns) 
424 
(143, 
648) 
-0.4  
(ns) 
426  
(143, 
1287) 
0  
(ns) 
 
Table 4.4 Characteristics of Study Infants: Quantitative Variables 
aR, Pearson’s correlation coefficient for correlation of variable and SOS SDS. P value 
significant if <0.05, ns=not significant.b Wks, weeks.c post term corrected age in weeks. 
d
 SOS, speed of sound in m/s, metres per second.eSDS, standard deviation score. 
f
 g, grams.gCRIB score, clinical risk index for babies score (21)h Phosphate, lowest serum 
phosphate recorded in the neonatal period, measured in mmol/l, millimoles per litre. 
i
 TPN, total parenteral nutrition.j ALP, peak serum total alkaline phosphatase recorded in the 
neonatal period. 
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Table 4.5 
 
0-6months 
CGA (n=15) 
6-12months 
CGA (n=10) 
12+months 
CGA (n=13) 
Study Group 
(n=38) 
Qualitative 
Variables 
n  p value a n p value n p value n p value 
IUGR b 2 ns 1  6 ns 9 ns 
Chronic lung disease c 10 ns 5 ns 3 ns 18 ns 
Hyperbilirubinaemia d  4 ns 1  1  6 ns 
Antenatal Steroids  14  10  13  37  
TPN duration > 2 
weeks e  
7 <0.05 3 ns 4 ns 16 ns 
ALP>1000u/l f 1  3 ns 0  4 ns 
 
Table 4.5 Characteristics of Study Infants: Qualitative Variables 
a
 p values for a significant effect of the variable on speed of sound standard deviation score 
(SOS SDS.) P value significant if <0.05, ns=not significant.b IUGR, intrauterine growth 
retardation, below 2nd percentile for weight on a standard UK growth chart. 
c Chronic lung disease, oxygen requirement at 36 weeks corrected gestational age. 
d
 Hyperbilirubinaemia, presence of a conjugated hyperbilirubinaemia, with conjugated 
bilirubin>10% of total serum bilirubin.e TPN, total parenteral nutrition. 
f ALP, peak serum total alkaline phosphatase recorded in the neonatal period. 
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Table 4.6 
 
 Early Group n=7 Late Group n=8 
 Median (Range) Median (Range) 
Gestation (wks)a 26 (25, 31) 27.5 (24, 31) 
Birthweight (g)b 870 (625, 1080) 1013 (740, 1460) 
CRIB scorec 4 (1, 9) 1 (1, 10) 
Phosphate (mmol/l)d 1.4 (0.9, 1.6) 1.1 (0.8, 1.6) 
TPN duration (days)e 16 (6, 120) 11 (5, 95) 
ALP (u/l)f 445 (163, 1096) 552 (175, 1287) 
Chronic lung disease  
(No infants)g 
7  5  
Antenatal steroids (No infants) 6  8  
Female (No infants) 5  5  
 
Table 4.6 Characteristics of Study Infants Followed Longitudinally 
a
 Wks, weeks.b g, grams.cCRIB score, clinical risk index for babies score (21) 
d
 Phosphate, lowest serum phosphate recorded in the neonatal period, measured in mmol/l, 
millimoles per litre.e TPN, total parenteral nutrition.f ALP, peak total serum alkaline 
phosphatase recorded in the neonatal period, measured in u/l, units per litre. 
g
 Chronic lung disease, oxygen requirement at 36 weeks corrected gestational age. 
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Figure 4.1 
 
Each line represents one patient’s speed of sound (SOS) measurements, measured with the CS 
probe. Birth gestation is by completed number of weeks at delivery. The dotted lines represent 
the manufacturers reference range, mean +/- 1 SD. 
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The relationship between serum total alkaline phosphatase (ALP, IU/L) and speed of sound 
(SOS) at the end of the study period. The closed circles represent tibial SOS in metres per 
second. R=0.6 p<0.05 
 
 
 
Figure 4.2
2400
2600
2800
3000
3200
0 500 1000 1500 2000 2500
Serum ALP (iu/l)
Sp
ee
d 
o
f S
ou
n
d 
(m
/s)
 76 
 
 
The relationship between CRIB score (116) and tibial speed of sound (SOS) at the end of the 
study. The closed circles represent tibial SOS in metres per second. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3
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Figure 4.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box plot showing the relationship between duration of total parenteral nutrition (TPN) and 
tibial speed of sound (SOS) at the end of the study. SOS (metres per second) is on the y axis. 
The black line represents the median values, the whiskers represent the range. 
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Figure 4.5 
 
 
 
 
 
 
 
 
 
 
 
The relationship between corrected gestational age and speed of sound. The closed circles 
represent each patient’s speed of sound in metres per second in patients measured only once. 
The open circles represent each speed of sound value in patients who had serial measurements, 
the first and subsequent values are joined by a solid line. These measurements were made 
using the CM probe. The solid line is the mean for age according to the manufacturers’ 
reference range, the dotted lines are +/- one and two standard deviations from the mean. 
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Figure 4.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Early group changes in speed of sound over time showing greatest percentage change in 
infants with the lowest speed of sound at term. The closed circles represent each patient’s 
increase in speed of sound in metres per second. 
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Chpt 5 Maternal factors and infant bone health at birth 
Introduction 
Maternal effects on the skeleton of her offspring can be mediated by both genes and the in 
utero environment. Maternal factors that have an effect on placental function and hormonal 
factors influencing growth are likely to be important for fetal bone development. A study of 50 
mother-infant pairs showed that mothers deficient in vitamin D had babies deficient in vitamin 
D, and that these infants had, relative to birthweight, a lower whole body and femur bone 
mineral content measured by DXA shortly after birth (107). Besides the short term effect on 
neonatal bone health, there is increasing evidence that the effect of the intrauterine 
environment may persist into infancy and childhood and perhaps even into adulthood. A 
relationship between maternal vitamin D levels in late pregnancy and the offspring’s 
childhood BMC at 9 years old has recently been described (99). A genetic influence on peak 
bone mass has been demonstrated however, current genetic markers can explain only a small 
proportion of the variation in individual bone mass or fracture risk (128) therefore it is likely 
that  early environment – genome interactions are influential in determining skeletal growth.  
A possible interaction in the human growth hormone gene, with weight at one year and rate of 
bone loss has also been recently reported (129). 
 
There is no consistent pattern to changes in bone mineral content in pregnancy, with both bone 
loss and bone gain reported in studies using DXA or SPA. Quantitative ultrasound has 
advantages for use in pregnant women and the newborn population as it is radiation free and 
portable. Recent studies using calcaneal quantitative ultrasound in the pregnant mother point 
to bone loss that is dependent on maternal lifestyle, fat stores and seasonality of early 
pregnancy (88). Two studies published in 2004 measured amplitude dependent speed of sound 
(AD-SOS) at the hand phalanges and found a decrease across pregnancy, with no correlation 
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between fetal growth or newborn size with changes in maternal AD-SOS.(89)To date, radial 
SOS, measured by axial transmission, to assess changes in bone health during pregnancy has 
not been studied. Furthermore, there are increasing reports of maternal vitamin D deficiency 
during pregnancy and it is unclear whether the extent of vitamin D deficiency changes during 
pregnancy and whether there is a relationship between changes in maternal vitamin D status or 
bone health and that of the offspring. 
Therefore, the following clinical study was designed to assess bone QUS status of pregnant 
women, to investigate the factors which influence maternal bone changes in pregnancy and the 
interaction between maternal bone status and that of her offspring. We also aimed to assess 
vitamin D status of mothers and infants and explore the link between vitamin D status and 
bone QUS measurements. 
 
Materials and Methods 
Study population  
Pregnant women attending for their first visit to the antenatal clinic of the Queen Mother’s 
Hospital between May 2006 and January 2007 were initially approached at the booking 
hospital appointment and informed consent was obtained in 188 women for a bone health 
study at booking and delivery, a further 22 women consented postnatally. Some of the women 
who consented antenatally subsequently miscarried or delivered still born infants. Information 
was collected on milk intake, recalled birthweight, history of fracture, age, confirmed 
gestation at booking, postcode, parity, time since last pregnancy, medical history, current 
medication, multivitamin intake and cigarette and alcohol intake. Mothers who had been 
smoking within the last 6 months were categorised as smokers. These details of the study 
participants are outlined in Table 5.1. The presence of gestational diabetes and hypertension, 
as well as medication during pregnancy was prospectively recorded from the case notes. 
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Season at early pregnancy was divided into spring and summer versus autumn and winter. A 
deprivation score was calculated based on postcodes which were allocated a data zone score 
from the 2006 Scottish Index of Multiple Deprivation (130). The Scottish Index of Multiple 
Deprivation (SIMD) identifies small area concentrations of multiple deprivation across 
Scotland using indicators in 7 domains: current income, employment, health, education skills 
and training, geographic access to services, housing and crime. The data zones scores are 
attributed population weighted deciles of 1= least deprived to 10= most deprived. There is also 
a record of which data zones contain the most deprived 15% of the population. For the 
newborn infants, anthropometric data and details on feeding were recorded. Infants had tibial 
length and circumference measured. Tibial length was measured from the top of the knee to 
the bottom of the heel with a calliper and at the midpoint of this measurement tibial 
circumference was measured in centimetres using a standard paper measuring tape. 
 
SOS Measurement of Mothers 
Out of a total of 210 women recruited into the study, 167 had a radial speed of sound (SOS) 
measurement at booking, and 113 out of these 167 also had a SOS following delivery at a 
mean age of 2 days (SD 1 day.) In addition 12 women had a single postnatal measurement, 
having missed the antenatal QUS. All SOS measurements were performed by a single operator 
using the Sunlight Omnisense 7000PTM scanner (Sunlight Medical, Israel) as described in 
chapter 3. This is the same method used by Weiss et al, and the result generated was converted 
to a standard deviation score (age and sex matched) using their published database (131).   
 
SOS Measurement of Infants 
Infants of all mothers participating in the study were eligible for a single tibial SOS 
measurement shortly after birth. One hundred and twenty five term infants (53 male) from 125 
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mothers had QUS measurements at a mean of 2 days old (SD 1 day.) Forty three infants were 
born and discharged when the QUS operator was unavailable. Thirty one preterm infants from 
22 mothers had QUS measurements in the first week of life. Median gestational age was 30 
weeks (10th, 90th percentiles 27, 33) and median birthweight was 1540g (1060, 1966). SOS 
was measured at the tibia using the Sunlight Omnisense 7000PTM scanner (Sunlight Medical, 
Israel) as described in chapter 3. Measurements were made by one single operator. 
 
Bone biochemistry 
A sample of blood was only collected from those study participants who were having other 
samples collected for clinical reasons at the booking clinic or around the time of delivery. An 
aliquot of this sample was analysed immediately for serum calcium, phosphate, albumin and 
alkaline phosphatase. The remaining serum was then frozen at -80oC and stored for analysis of 
25-hydroxy vitamin D (25VitD) and PTH. 25-hydroxy vitamin D levels were measured by 
tandem mass spectrometry after solid phase extraction as described by Knox et al (132). Both 
intra and inter- assay precisions are <10% over the assay range for both 25-hydroxyvitamin 
D3 and D2. Assay sensitivity for D3 was 5nmol/L and for D2 7 nmol/L 
 
Serum vitamin D3 level of <25nmol/l was considered vitamin D deficient, between 25 and 55 
nmol/l was insufficient, and >55 nmol/l was considered sufficient. Intact parathyroid hormone 
was analysed by solid phase two site chemiluminescent enzyme-labelled immunometric assay 
using the Immulite 2000TM (Siemens Medical Solutions, 5210 Pacific Concourse Drive, Los 
Angeles, CA 90045-6900). Sensitivity was 0.3 pmol/l and CV at 5.8 was 8.3% and at 33.8 was 
9%. Sufficient samples were available to measure serum calcium, phosphate, albumin and 
alkaline phosphatase in 151 and 49 women antenatally and at delivery, respectively; for 
25VitD, the respective figures were 140 and 42 women; for PTH, the respective figures were 
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122 and 33. Umbilical cord calcium, phosphate, albumin, alkaline phosphatase and vitamin D 
was obtained in 45 infants, and was sufficient for PTH in 28 infants. Blood was taken from the 
umbilical vein immediately after delivery of the placenta and was stored and analysed in an 
identical manner to the serum samples. 
The study had approval from the hospital research ethics committee and all participants gave 
written informed consent. 
 
Statistical Analysis 
Data analysis was carried out using Minitab Release 14.1 statistical software (Minitab Inc.) 
and data were described as medians and 10th and 90th centiles. Correlation (Pearson’s) 
methods were used to explore the determinants of maternal SOS, infant SOS and the 
relationship between these. Wilcoxon Signed Ranks tests were used to test for differences in 
SOS SDS at the start and end of pregnancy. Mann Whitney tests, comparing medians, were 
used to determine differences between groups. Fisher’s exact test was used to compare 
unpaired binary data. Significant factors in univariate analyses were entered into multiple 
regression analysis. Significance was taken as p<0.05. A sample size of 147 provided 95% 
power to detect a 0.3 SD change. 
 
Results 
Maternal Vitamin D Status 
Vitamin D2 levels were undetectable (<7.5 nmol/l) in all women, including those who 
reported the use of multivitamins. At booking, median serum vitamin D3 (n, 140.) was 
66nmol/l (24, 120) and median PTH (n, 122) was 1.8nmol/l (0.9, 4.6). Based on these Vitamin 
D3 levels, 59% of mothers were vitamin D sufficient, 29% were insufficient, 11% were 
deficient at booking. At delivery, median serum vitamin D3 (n, 42) was 26nmol/l (7, 63) and 
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median PTH (n, 33) was 3.8nmol/l (1.4, 7.6). Based on these Vitamin D3 levels, 19% of 
mothers were sufficient, 31% insufficient, 50% deficient. There was a significant difference 
between Vitamin D3 levels at booking and delivery (p<0.001) (figure 5.1). PTH was 
significantly higher at delivery (p<0.01). Median PTH: vitamin D3 ratio was 0.027 (0.009, 
0.13) antenatally, and increased significantly by delivery 0.13 (0.03, 0.84) (p<0.005.) Serum 
calcium and alkaline phosphatase levels were within the normal reference range in all study 
participants at all time points.  Serum phosphate levels were low at booking in 2 women and at 
delivery in 4 women and ranged between 0.75 and 2.82 mmol/l. 
 
Infant Vitamin D Status & Its Link To Maternal Status  
Out of 110 infants, cord samples were available in 45 infants for analysis. Median umbilical 
cord vitamin D3 was 23nmol/l (7, 51). Umbilical cord vitamin D levels were sufficient in 9% 
of infants, insufficient in 44%, and deficient in 47%. Although, there was no correlation 
between maternal vitamin D at booking and umbilical cord vitamin D (r,0.1, NS), there was a 
strong positive correlation between maternal vitamin D at delivery and umbilical cord vitamin 
D (r,0.7, p<0.001) (fig 5.2). PTH was <1.0 on 42 out of 45 cord blood samples. The remaining 
3 PTH levels were 1.7, 3 and 3.2, the maternal samples for these 3 infants were insufficient in 
2 samples, but the 1 result available was 25.6, the highest PTH of any woman at delivery. 
 
Parity, Deprivation, Smoking Status and BMI and maternal/ infant Vitamin D 
Women residing in an area of deprivation did not have significantly lower vitamin D 
antenatally, postnatally or in umbilical cord, medians 69nmol/l (31, 101), 14nmol/l (8, 21), 
and 25nmol/l (0, 40) respectively, compared to medians of 61nmol/l (23, 123), 31nmol/l (7, 
64), and 23nmol/l (3, 55) when women were not resident in the most deprived areas, ns. 
Women who smoked cigarettes had slightly lower vitamin D antenatally, postnatally and in 
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umbilical cord samples, median 58 nmol/l (30, 94), 19 nmol/l (14, 32), 15 nmol/l (5, 26) 
respectively, compared to non smokers, 68 nmol/l (24, 123), 27 nmol/l (7, 64) and 31 nmol/l 
(7, 54), however this did not reach statistical significance. Obesity only had a significant effect 
on antenatal vitamin D, a lower median of 46nmol/l (25, 89) compared to 70nmol/l (25, 127) 
in non obese women (p<0.005.). Higher PTH antenatally was also found in obese women, 
median 2.7 (1.6, 7.8) compared to 1.6 (0.9, 4.2) in women with a normal BMI (p<0.005), but 
not in smokers, median 1.9 (2.7, 17), compared to non smokers, median 1.8 (1.4, 7.0) (NS). 
Obesity had no significant effect on PTH: vitamin D3 ratio, median 0.02 in women with 
BMI<30, and 0.07 in obese women (NS). Also the PTH: vitamin D3 ratio was not 
significantly different between smokers and non smokers, median 0.113 and 0.14 respectively, 
(NS). 
 
Race, Head Coverings, Seasonality and maternal/ infant Vitamin D levels 
At booking, median vitamin D levels in non-caucasian (n, 18) and caucasian women (n, 122) 
were 23nmol/l (7, 36) and 70nmol/l (32, 123), respectively (p=0.0000) (fig 5.1). South-asian 
women with head coverings (n, 6) had the lowest vitamin D levels at booking with a median 
value of 18.5nmol/l (7, 30) and significantly lower than the other women (n, 134), p=0.0003 
(figure 5.1). Median vitamin D at delivery was lower at 10nmol/l (8, 16) in the non-caucasian 
women (n, 3) compared to 27nmol/l (7, 63) in caucasian mothers (n, 39) but this did not reach 
significance (p=0.09) (fig 5.1). Median umbilical vitamin D was 25nmol/l (0, 53) in caucasian 
infants. Only 2 infants of south-asian origin had cord vitamin D measured and they were both 
undetectable. A significant association with season and vitamin D levels was only evident for 
maternal vitamin D levels at booking where the median vitamin D level, in mothers booking in 
spring and summer median was 70nmol/l (30, 127) and in autumn and winter was 57nmol/l 
(14, 98) (p=0.02). This association was not evident for maternal vitamin D at delivery or 
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umbilical cord vitamin D. At booking, median serum PTH was 3.3 (1.5, 10) and 1.7 (0.9, 3.7) 
in non-caucasian and caucasian women, respectively (p=0.001), and higher in those women 
who kept their skin covered (n, 5) at median 3.3 (2.4, 7.7) compared to 1.8 (0.9, 4.5) in non 
covered women (n, 117), p=0.01. PTH: vitamin D3 ratio was significantly higher at booking 
in non caucasian women, median 0.3 (0, 0.7) than in caucasian women, median 0.03 (0, 0.1) 
(p=0.003). The ratio was similar for covered and non covered women (NS).  
 
Multivitamin Supplementation 
Out of the 167 women, 19 (11%) were taking vitamin supplements at booking. However, these 
women as well as the rest of the cohort had undetectable vitamin D2 levels at booking and 
delivery. These women did, however, have a higher vitamin D3 levels at booking with a 
median value of 82nmol/l (67, 154) compared to those not on multivitamins with a median of 
59 nmol/l (23, 120) (p= 0.01). There was no difference between the vitamin D levels of the 
two groups at delivery and neither was there a difference between the umbilical cord vitamin 
D levels of the offspring of the two groups of mothers.  
 
Maternal SOS 
One hundred and sixty seven women, median age 32 yrs (22, 38) had a median antenatal SOS 
measurement of 4147 m/s (3993, 4360) which converted to a median SOS SDS of 0.0 (-1.4, 
2.3) In 10 women, the SOS SDS was less than -2.0, and in 17 was greater than 2.0. There was 
a strong significant correlation with age, r=0.4 p<0.001, therefore all associations between 
variables were tested using SOS SDS rather than SOS values, to correct for age. Median 
postnatal SOS in the mothers who had both an antenatal and postnatal measurement (n=111), 
was 4134m/s (3986, 4317) and median SOS SDS was 0.0 (-1.7, 1.6) in the immediate 
postnatal period. Median change in SOS SDS was 0 (-2.4, 1.6) across pregnancy (NS)  
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Women who had a decrease in SOS SDS (n=56) had a significantly higher median SOS SDS 
antenatally compared to those who had an increase in SOS SDS over pregnancy (n=57), 0.9 
and -0.4 respectively, p<0.0001. 
 
Infant SOS & Its Link To Maternal SOS 
Median gestation of the infants was 40 weeks (38, 41) and the median birthweight was 3450g 
(2867, 4122), length was 51cm (46, 55) and occipitofrontal circumference (OFC) was 35cm 
(33, 36.6.) The median tibial SOS SDS at birth was -0.4 (-1.3, 0.6). Two infants had a SOS 
which was below -2 SDS and no infant had a SOS SDS of greater than 2. There was a 
significant negative correlation between infant SOS SDS and birthweight, r,-0.3, p<0.005 , but 
there was no correlation with length or OFC. Tibial length and circumference was recorded in 
96 infants, tibial circumference divided by tibial length had a median value of 0.86 (0.78, 
0.94) so tibial circumference was most frequently 86% of tibial length. We used the tibial 
circumference:length ratio as a proxy for the amount of soft tissue present in the lower leg; the 
higher the ratio, the greater amount of soft tissue relative to leg length. There was a significant 
negative correlation between SOS SDS and tibial circumference:length, r= -0.2, p<0.05. 
Neither maternal SOS SDS (antenatal and postnatal) nor change in maternal SOS SDS during 
pregnancy correlated significantly with the SOS SDS of her offspring. Although the median 
birthweight, head circumference and SOS SDS of the babies born to mothers who had an 
increase in SOS SDS was similar to that of babies born to mothers who showed a decrease, the 
median length was greater at 52cm (47.5, 56) compared to 50cm (46, 53) (p<0.005).  
 
Parity, Deprivation, Smoking Status and BMI and maternal/ infant SOS 
Out of the 167 mothers, 27 (16%) lived within the 15% most deprived areas in Scotland as 
categorised by the Scottish Index of Multiple Deprivation (130).  Median SOS SDS of women 
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in this band was 0.3 (-1.2, 2.4) compared to 0.0 (-1.9, 2.3) for the rest of the cohort (NS). In 
addition, change in SOS SDS during pregnancy, infant SOS SDS as well as all measures of 
infant anthropometry were similar in the two groups. Out of the 167 mothers, 77 (46%) 
women were primigravid. At booking, median SOS SDS was -0.15(-2.0, 2.4 0 in these women 
compared to 0.3(-1.3, 2.3) in parous women (ns). In addition, change in SOS SDS during 
pregnancy, infant SOS SDS as well as all measures of infant anthropometry were similar in 
the two groups. The median SOS SDS in the 29 women who were smokers was -0.6 (-2.6, 2.2) 
compared to 0.3 (-1.2, 2.4) in the 92 non-smokers, p<0.005. Postnatal SOS SDS was also 
lower in smokers at -0.6 (-1.9, 1.1) compared to non smokers at 0.1 (-1.5, 1.7) (NS). The 
median SOS SDS in infants of smokers was -0.75 (-1.8, 0.5), compared to -0.3 (-1.3, 0.6) in 
infants of non smokers (p<0.05) (Figure 5.3) There were no significant differences in 
birthweight, length or OFC between infants of smoking or non smoking women. Median 
maternal BMI at booking was 25 (20, 32) and there was a significant negative correlation with 
SOS SDS (r,-0.2, p<0.01) (Figure 5.4), There was no significant relationship between BMI at 
booking and change in SOS SDS during pregnancy, or any measure of infant anthropometry.  
 
Race, Head Coverings, Seasonality and maternal/ infant SOS 
In caucasian and non-caucasian women, median SOS SDS at booking was similar at 0 (-1.4, 
2.3) and 0.3 (-1.4, 1.7) respectively. Median change in SOS SDS from booking to post-natal 
measurement pregnancy was 0 (-2.5, 1.8) in caucasian and -0.2 (-2.3, 1.2) in non caucasian 
women (NS). The median SOS SDS of a subgroup of 5 women of South-Asian origin who 
wore head coverings for religious reasons was 1.5(0.3, 4.4) and not significantly different 
from the rest of the cohort. However, median change in SOS SDS in this group was -1.8 (-3.6, 
-0.8) and this was significantly different from the median change in SOS SDS in the rest of the 
cohort of 0.05 (-2.4, 1.8) (p=0.000) (Figure 5.5). Median SOS SDS at booking in spring and 
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summer and in autumn and winter was 0.3 (-1.4, 2.6) and -0.1 (-1.4, 1.2) respectively (ns). 
However, the mothers who booked in spring and summer showed a median change in SOS 
SDS of -0.3 (-2.5, 1.3) whereas the remainder showed an increase of 0.35 (-1.7, 2.1) (p=0.02). 
Season at booking had no significant association with infant SOS SDS or anthropometry. 
When smoking status, BMI and maternal covering was entered into a multiple linear 
regression model for effect on antenatal SOS SDS all 3 factors remained significant and 
explained 15% of the value. When the same factors were entered for effect on change in SOS 
SDS only maternal skin covering remained a significant factor (p=0.03).  
 
Vitamin D and SOS  
Women who were deficient in vitamin D at booking had a median SOS SDS of -0.1 (-1.1, 1.5) 
and 0.5 (-1.7, 1.1) at booking and delivery, respectively and this was similar to the mothers 
who were not vitamin D deficient who had a median SOS SDS of 0.05 (-1.4, 2.3) and -0.15 (-
1.7, 1.6) at booking and delivery, respectively (NS).  The median SOS SDS of those mothers 
who were vitamin D deficient at delivery was 0.5 (-1.2, 1.7) and similar to the rest of the 
cohort at -0.05 (-2.7, 0.9) (NS). Median SOS SDS in the infant was 0.0 (-0.9, 0.4) when their 
mothers were vitamin D deficient at booking and -0.4 (-1.3, 0.6) when mothers were not 
vitamin D deficient at booking (NS). Median SOS SDS was -0.6 (-1.6, 0.2) in those infants 
whose mothers were deficient at delivery, and -0.8 (-1.3, 0.6) in those whose mothers were not 
deficient (NS). There was no relationship between maternal vitamin D or umbilical cord 
vitamin D and infant SOS or infant size. In addition, change in SOS SDS during pregnancy, 
infant SOS SDS as well as all measures of infant anthropometry were similar in the two 
groups. There was no correlation between antenatal PTH and maternal or infant SOS SDS. 
However, there was a negative correlation between maternal PTH at booking and infant birth 
weight r,-0.2, p=0.04, and birth length r,-0.34, p=0.002 (figure 5.6 and 5.7). At delivery, 
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maternal PTH had no significant correlation with SOS SDS or infant anthropometry. The 
PTH: vitamin D3 ratio did not correlate with antenatal SOS SDS, postnatal SOS SDS or 
change in SOS SDS. 
 
Discussion 
SOS is a promising measure of bone health in pregnant women. In our cohort, median SOS 
SDS in early pregnancy was 0, which suggests that our study participants, women of child 
bearing age, had normal bone health at the start of the study. Our data would support current 
evidence that bone is not usually lost during pregnancy and that the maternal skeleton is 
protected while adaptive responses allow for adequate mineralisation of the fetal skeleton 
(133) This would seem to be the case in nutritionally adequate and vitamin D sufficient 
women.  
 
Vitamin D deficiency in early pregnancy was almost exclusively found in women of south 
asian origin, the lowest values in those who were covered. PTH was also significantly higher 
in these women. During the pregnancy, those south asian mothers who kept their skin covered 
had a reduction in SOS that was 17 times greater than the decrease in the caucasian and asian 
mothers with more exposed skin, but interestingly, their infants had normal SOS at birth. By 
the end of pregnancy, vitamin D deficiency was present in both caucasian and non-caucasian 
mothers. It was interesting to note that none of the mothers, even those who were taking 
supplements had detectable Vitamin D2 suggesting that current methods of supplementation 
were inadequate. Caucasian women taking multivitamin supplementation had a slightly higher 
serum vitamin D3 level in early pregnancy and it is possible that this may reflect lifestyle. 
There was a trend towards a correlation between maternal vitamin D at the end of pregnancy 
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and SOS SDS, so it may be that there is a lag between becoming vitamin D deficient and the 
bone changes associated with it to be seen on QUS.  
 
In our cohort the mothers who had a decrease in SOS SDS during pregnancy started off with a 
higher SOS SDS antenatally. This was a similar finding to Sowers et al (134) who attributed it 
to a greater bone mass giving more cancellous bone surfaces available for turnover. This may 
indeed be the case as Shahtaheri et al (135) demonstrated fluctuations in cancellous bone 
transilial biopsy specimens during pregnancy. In early pregnancy the quantity of cancellous 
bone was lower than in controls, primarily due to a decline in trabecular thickness, which was 
entirely restored by term by addition of new trabeculae.   
Pregnancy is a high oestrogen state that should, through inhibition of osteoclasts recruitment 
and activity, maintain bone mass. The observation of a direct association between the change 
in maternal SOS SDS and the length of the offspring is intriguing. Women with an increase in 
SOS SDS during pregnancy had larger babies whilst women with a reduction in SOS SDS had 
smaller babies. It, therefore, seems that the positive effect on the maternal skeleton is mirrored 
in the birth size.  
 
Lifestyle factors which negatively affected bone SOS SDS were cigarette smoking and 
obesity. The association between smoking and bone health was particularly clear at booking, 
the lower impact on postnatal bone health and vitamin D status may have been due to a 
reduction in the amount of cigarettes smoked while pregnant as well as other contributory 
factors playing a more important contributory role on bone health during pregnancy. The 
increased likelihood of vitamin D deficiency in obese women has been described before (136) 
and our studies confirm the existence of this association in pregnant women too. Whilst both 
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smoking and obesity can be associated with social deprivation, deprivation scores by 
themselves did not show any association with SOS, infant size or vitamin D status. 
 
In our unselected group of preterm infants median SOS SDS was -0.4, rather than the expected 
0. It may be that there was a systematic error in the measurement of SOS in these infants. 
However this would be unlikely as the operator was the same as in our previous cross-
sectional study of term infants, also measured shortly after birth, and absolute values of SOS 
were then found to be comparable to the manufacturer’s reference range. 
 
In conclusion, vitamin D deficiency, smoking and obesity may adversely affect the bone 
health of women.  Vitamin D deficiency is common in pregnancy and becomes more 
pronounced during pregnancy, and south asian women are at particularly high risk. Whilst the 
bone health of the fetus, as assessed by QUS seems to be protected, the vitamin D deficient 
neonate is likely to be at risk of other sequelae of early vitamin D deficiency. Women living in 
Scotland should be supplemented with adequate amounts of vitamin D. There is a need to 
study longer-term functional outcomes of vitamin D deficiency in pregnant women and their 
offspring. 
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Table 5.1 
 
 
 All Study 
Participants 
n=210 
Antenatal Group 
n=167 
Postnatal Group 
n=34 
No QUS 
n=9 
 
 median 10th,90th median 10th,90th median 10th,90th median 10th,90th 
Age  31 21, 38 32 22, 38 30 20, 38 31 26, 38 
BMI1  24 20, 32 25 20, 32 23 20, 32 24 21, 27 
SIMD 
decile2 
 5 1,10 5 1, 10 6 1, 10 2 1, 9 
yes  40 27 11 2 15% most 
Deprived3 no 170 140 23 7 
caucasian 188 146 34 8 
asian 16 15 0 1 
Race 
other 6 6 0 0 
yes 45 29 13 3 Smoking 
no 162 138 18 6 
none 64 53 0 4 
pre-
pregnancy 
9 106 26 5 
Alcohol 
during 
pregnancy 
137 8 1 0 
primigravid 102 77 22 3 Parity 
parous 108 90 12 6 
spring 36 29 7 0 
summer 71 63 6 2 
autumn 64 45 12 7 
Season 
early 
pregnancy 
winter 39 30 9 0 
yes 20 19 1 0 Vit D 
suppl no 190 148 33 9 
<0.5 
pint/day 
 80 7 0 
>0.5 
pint/day 
 60 8 0 
Milk 
intake 
unsure  27 19 9 
yes  34 1 0 
no  130 27 0 
Childhood 
fracture 
unsure  3 6 9 
 
Table 5.1 Characteristics of Study Participants 
1- BMI, body mass index, 2- SIMD decile, Scottish Index Multiple Deprivation decile score 
(124), 3- 15% most deprived, in the 15% most deprived area of Scottish population according 
to the SIMD (124). 
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Table 5.2 
 
Lifestyle Factors/Demographics N Median SOS SDS  10th ,90th centiles  P value 
Cigarette Smoking     
     Y 29 -0.50 -2.26, 0.72 <0.005 
     N 138 0.20 -1.24, 2.31  
BMI >30     
     Y 30 -0.10 -2.1, 1.94 0.13 
     N 133 0.10 -1.29, 2.4  
Multivitamins     
     Y 19 -0.20 -1.0, 3.60 0.99 
     N 148 0.10 -1.40, 1.96  
Resident In Deprived Area     
     Y 27 0.30 -1.14, 1.94 0.42 
     N 139 0.00 -1.41, 2.05  
Parous     
     Y 90 -0.05 -1.21, 1.99 0.65 
     N 77 0.10 -1.78, 2.16  
Season of early pregnancy     
     Autumn/winter 76 -0.1 -1.41, 1.24 0.12 
     Spring/summer 91 0.3 -1.35, 2.58  
Childhood fracture     
     Y 34 -0.40 -1.35, 1.87 0.25 
     N 130 0.15 -1.40, 2.29  
Low milk intake     
     Y 80 0.30 -1.21, 2.08 0.15 
     N 60 -0.10 -1.78, 2.11  
Race     
     Non caucasian 21 0.30 -1.36, 1.69 0.97 
     Caucasian 146 0.00 -1.41, 2.32  
Covered skin     
     Y 8 0.95 -1.49, 3.11 0.38 
     N 159 0.00 -1.41, 2.08  
 
Table 5.2 Demographics and Lifestyle factors And SOS SDS in Early Pregnancy 
All values are medians 
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Table 5.3 
 
Lifestyle 
Factors/Demographics 
N Booking 
SOS SDS 
centiles p 
value 
Delivery 
SOS SDS 
centiles p 
value 
SOS 
SDS 
Change 
centiles p 
value 
Cigarette Smoking           
     Y 21 -0.6 -2.6,2.2 0.001 -0.6 -1.9,1.1 0.06 0.3 -1.1,1.8 0.16 
     N 92 0.3 -1.2,2.4  0.1 -1.5,1.7  -0.05 -2.4,1.7  
BMI >30           
     Y 22 0.1 -2.0,2.0 0.3 -0.35 -1.8,1.6 0.31 0.25 -2.5,1.5 0.79 
     N 87  -0.5,2.5  0.10 -1.4,1.6  0.00 -2.4,1.9  
Multivitamins           
     Y 13 -0.2 -0.9,2.1 0.45 -0.2 -1.1,1.7 0.92 0 -2.2,2.5 0.62 
     N 100 0.2 -1.8,2.3  0.05 -1.7,1.6  0 -2.5,1.6  
Resident In Deprived 
Area 
          
     Y 22 0.35 -1.2,2.4 0.69 -0.35 -1.1,1.9 1.00 -0.05 -3.3,1.6 0.81 
     N 91 0.0 -1.9,2.3  0.1 -1.6,1.5  0.0 -2.3,1.8  
Parous           
     Y 57 0.3 -1.3,2.3 0.08 0.50 -1.6,1.9 0.10 0.1 -2.9,1.8 0.83 
     N 56 -0.15 -2.0,2.4  -0.2 -1.5,0.9  -0.1 -2.3,1.7  
Season at Booking           
     Autumn/winter 48 -1.5 -1.7,2.0 0.06 0.1 -1.2,1.5 0.36 0.35 -1.7,2.1 0.02 
     Spring/summer 65 0.4 -1.6,2.6  -0.2 -1.7,1.6  -0.3 -2.5,1.3  
Childhood fracture           
     Y 27 0 -1.3,2.3 0.88 0 -2.1,1.8 0.88 0.00 -2.9,1.5 0.89 
     N 83 0.1 -1.7,2.4  0.1 -1.5,1.5  -0.1 -2.4,1.8  
Low milk intake           
     Y 60 0.3 -1.1,2.5 0.18 0.2 -1.4,1.5 0.88 -0.1 -2.4,1.5 0.31 
     N 34 -0.05 -2.1,2.2  0.1 -1.7,1.6  0.4 -2.4,1.9  
Race           
     Non caucasian 13 0.4 -1.0,1.9 0.61 0.8 -1.5,1.6 0.44 -0.2 -2.3,1.2 0.57 
     Caucasian 100 0.05 -1.8,2.4  0.00 -1.5,1.6  0.00 -2.5,1.8  
Covered skin           
     Y 5 1.5 0..3,4..3 0.05 0.8 -1.8,1.2 0.75 -1.8 -3.6,-
0.8 
0.000 
     N 108 0 -1.8,2.3  0 -1.6,1.6  0.05 -2.4,1.8  
Table 5.3 Demographics and Lifestyle factors And Change In SOS SDS Across Pregnancy 
All values are medians 
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Table 5.4 
 
Lifestyle 
Factors/Demographics 
N SOS 
SDS 
centiles p value N Birth 
weight 
centiles p value N Length centiles p value N OFC centiles p value 
Cigarette Smoking                 
     Y 20 -
0.75 
-1.8,0.5 0.04 27 3500 2955,4381 0.75 18 50.5 47,55.7 0.71 27 35 32.4,36 0.78 
     N 90 -0.3 -1.3,0.6  126 3435 2910,4160  97 51 47.54.7  117 35 33,36.6  
BMI >30                 
     Y 21 -0.3 -1.6,0.4 0.93 28 3610 2982,4408 0.65 18 51 47.7,56.6 1.0 25 35 33.5,37 0.50 
     N 86 -0.4 -1.3,0.5  122 3435 2888,4145  94 51 46.9,55  116 35 33,36  
Multivitamins                 
     Y 13 -0.5 -1.3,0.7 0.70 17 3490 2872,4348 0.33 13 52 48.9,56 0.50 14 35.5 35,37 0.04 
     N 97 -0.4 -1.1,0.1  136 3448 2917,4049  102 51 46.7,54.3  130 34.7 33,36  
Resident In Deprived 
Area 
                
     Y 21 -0.4 -1.1,0.1 0.90 26 3268 2920,3810 0.07 15 53 46.3,54.4 0.56 24 35 32.7,35.7 0.93 
     N 89 -0.4 -1.4.0.7  127 3495 2910,4194  100 51 47,55  120 35 33,36.5  
Parous                 
     Y 54 -0.3 -1.3,0.5 0.33 84 3515 2930,4135 0.14 64 51 47,56.4 0.84 78 34.9 33.4,36.6 0.47 
     N 56 -
0.55 
-1.4,0.8  69 3370 2884,4176  51 51 47.2,53  66 35 32.8,36  
Season of early 
pregnancy 
                
     Autumn/winter 47 -0.3 -1.1,0.9 0.37 66 3435 2610,4305 0.31 46 51 47.2,55.6 0.67 62 34.8 32.5,36 0.59 
     Spring/summer 63 -0.4 -1.5,0.5  87 3470 3011,4058  69 51 47,054.8  82 35 33,37  
Childhood fracture                 
     Y 26 -0.5 -1.2,0.4 0.39 32 3500 2957,4082 0.76 22 50.8 47,52.5 0.22 29 35 32.8,36 0.60 
     N 82 -0.4 -1.4,0.8  119 3450 2911,4179  91 51 47,56  113 35 33,36.5  
Low milk intake                 
     Y 60 -0.4 -1.3,0.9 0.99 75 3440 2814,4133 0.99 56 51 47.5,54 0.57 69 35 32.5,36.4 0.63 
     N 32 -
0.25 
-1.3,0.4  55 3445 2920,4180  40 51 46.1,56.6  53 34.5 33,36.6  
Race                 
     Non caucasian 13 -0.1 -0.7,0.4 0.15 19 3125 2734,3593 0.007 16 50.5 46,53 0.2 19 34 33,35.5 0.03 
     Caucasian 97 -0.4 -1.4,0.7  134 3495 2961,4183  99 51 47,55.4  125 35 33,36.5  
Covered skin                 
     Y 5 0.0 -1.3,0.3 0.67 8 3128 3002,3327 0.09 8 49.5 45.8,51.9 0.26 8 34 33,34.6 0.09 
     N 105 -0.4 -1.3,0.7  145 3480 2908,4175  107 51 47,55  136 35 33,36.5  
 
  Table 5.4 Demographics and Maternal Lifestyle Factors And Offspring SOS SDS /Growth 
  All values are medians
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Figure 5.1 
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  Boxplot showing vitamin D3 levels across pregnancy in caucasian and non caucasian 
women, and in their offspring. The boxes represent the interquartile range, with the 
median marked as a straight line, and outliers are marked as diamonds. The asterisks 
show a statistical difference at p<0.05 
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Figure 5.2 
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The closed circles represent vitamin D3 levels in mother-infant pairs. R=0.7, p<0.001 
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Figure 5.3 
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This box plot shows antenatal speed of sound standard deviation score (AN SOS SDS), 
postnatal speed of sound standard deviation score (PN SOS SDS) and infant speed of sound 
SDS (infant SOS SDS) in smoking and non-smoking mothers. The boxes represent the 
interquartile range with the median marked as a straight line, and the outliers marked as 
diamonds. 
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Figure 5.4 
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  The closed circles represent each patient’s antenatal SOS SDS, speed of sound 
standard deviation score, plotted against their BMI, body mass index. 
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Figure 5.5 
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This box plot shows the change in speed of sound standard deviation score (SOS SDS) across 
pregnancy, in women who kept their skin covered and women who did not. The median is 
represented by a horizontal line, the boxes extend to the interquartile range and the diamond 
shapes are the outliers. 
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Figure 5.6 
 
 
 
The closed circles represent the birthweight of offspring plotted by maternal antenatal serum 
parathyroid hormone (PTH). 
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Figure 5.7 
 
 
 
 
The closed circles represent birth length of offspring plotted against maternal antenatal serum 
parathyroid hormone (PTH) 
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Chapter 6 Passive exercise as an intervention for improving bone health in preterm 
infants 
 
Introduction 
Skeletal growth is driven by functional requirements. Both spontaneous movement and 
exercise has been related to changes in bone speed of sound (SOS) (55;58). The mechanostat 
theory of a functional model of bone development suggests that bone cell action is coordinated 
by the mechanical requirements of the bone; and thus can be modified by influencing muscle 
force or longitudinal bone growth (51). Minimal handling of preterm infants is becoming 
routine in neonatal units, and may contribute to the suboptimal bone mineralisation of these 
infants by lack of muscle stimulation. Moyer-Mileur (56) enrolled preterm infants aged 2 to 4 
weeks old to a physical activity programme consisting of range of motion exercises with 
gentle compression, extension and flexion of both upper and lower limbs. Each movement was 
done 5 times at each joint five times each week, and the infants receiving this had at the end of 
the study period (when they had reached a weight of 2kg) a higher mean radial BMC 
measured by SPA compared to controls. The same physical activity programme was repeated 
in 2000 (57)and the infants then assessed by DXA, infants in the exercise group had larger 
forearm bone area, but there were no differences in forearm BMC or BMD when compared to 
the control group. This study group had DXA and anthropometry followed up at 12 months 
corrected age and there were no differences detected between the intervention and control 
groups. Litmanovitz et al (58) used the same exercise protocol designed by Moyer-Mileur but 
started the physical activity when the infants were immediately cardiovascularly stable and 
continued for only 4 weeks. Over this 4 weeks there was an attenuation in the decrease in bone 
speed of sound measured by QUS in the infants receiving physical activity. So, the optimum 
timing, frequency and duration of exercise remain unanswered questions. There are currently 
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no studies which have reported on both the short and longer term effects of passive exercise 
(e.g. on neurodevelopment) in preterm infants. The hypothesis that the intervention of passive 
exercise in preterm neonates will safely improve their bone health will be evaluated in this 
clinical study. 
 
Materials and Methods 
Study Population 
Following approval from the Local Research Ethics Committee, 31 preterm infants were 
recruited (13 female) were recruited during the period May 2006 to February 2007 from the 
neonatal unit in the Queen Mother’s Hospital, Glasgow. One infant was transferred back to his 
district general hospital at 3 weeks old and was therefore excluded from further analysis. The 
study group included 7 sets of twins (4 same sex.) Median gestational age was 30 weeks (10th, 
90th percentiles 27, 33) and median birthweight was 1540g (1060, 1966). There were no 
significant differences in gestation or size at birth between infants in the early exercise group 
and those in the late exercise group (Table 6.1). Routine clinical and anthropometric data, 
including details of respiratory complications and serum biochemistry were collected. Median 
duration of total parenteral nutrition (TPN) for the whole study group was 6 days (1.9, 16). As 
3 of the infants were discharged at 3 weeks old, data on nutritional intake over the first 3 
weeks of life was analysed, with average daily calcium, phosphate, and calorie intake 
calculated over this period. Once discharged from hospital the infants were followed up in the 
out patient clinic, and data on growth, feeding, fracture, presence of skeletal deformities and 
neurodevelopmental progress was recorded. 
 
A group of previously studied (ref- chapter 4 in thesis) were used as historical controls. Each 
study infant was paired with 2 different gestation matched historical controls, (therefore some 
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of the historical controls were used more than once) to compare SOS SDS and serum alkaline 
phosphatase only. There had been no significant changes in newborn care in the neonatal unit 
in the time between studies, eg the same TPN preparations were used across both study 
periods. 
 
SOS Measurement of Infants 
SOS was measured at the tibia using the Sunlight Omnisense 7000PTM scanner (Sunlight 
Medical, Israel) as described in chapter 3. Weekly measurements were made by one single 
operator (HM) in the neonatal unit unless the infant was too unstable to tolerate the procedure, 
or if access to the tibia was difficult, e.g. because of intravenous cannulation. Measurements 
were also performed at each out-patient clinic visit following hospital discharge. 
 
Passive exercise protocol 
Range of motion passive exercises of upper and lower limbs were performed as previously 
described by Moyer-Mileur (57). Flexion and extension movements with gentle compression 
at the ankle, knee, hip, wrist, elbow and shoulder were done five times at each joint five times 
each week. Infants were randomised by computer to either ‘early’ or ‘late’ exercise protocol. 
A random number was generated by computer for each sequential patient, odd random 
numbers were allocated to ‘early’ exercise, and even random numbers were allocated to ‘late.’ 
Early exercise was started as soon as the infant was cardiovascularly stable. Late exercise 
commenced once the infant was on 100kcal/kg/day of milk feeds. No stratification was made 
for twins due to the small numbers in the study. Both exercise protocols involved 5 minutes of 
exercise 5 times a week until hospital discharge. Exercises were performed by HM in all 
infants. There were 14 infants in the early group (1 excluded infant was randomised to early 
group) and 16 in the late group. The infants in the early group started the range of motion 
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protocol at a median of day 5 (3, 7), and the late group day 11 (6, 17), and in both groups 
continued until discharge. Table 6.1 shows the characteristics of infants in each group.  
 
Statistical Analysis 
The data were summarised as medians and 10th and 90th percentiles. Wilcoxon Signed Ranks 
test was used to test for differences in SOS SDS at the start and end of the study period. Mann 
Whitney U tests were used to determine differences between groups. Fisher’s exact test was 
used to compare unpaired binary data. Pearson’s correlation method was used to analyse the 
associations between SOS SDS and other continuous variables. Data analysis was performed 
with Minitab Release 14.1 statistical software (Minitab Inc.). 
 
Results  
Initial SOS SDS 
In the ‘early’ group median SOS at the enrolment to the study was 2986 m/s (10th, 90th centiles 
2864, 3098) and SOS SDS was 0.4 (-0.8, 1.3.) This was similar to the ‘late’ group, with 
median SOS 2982m/s (2874, 3086) and SOS SDS 0.1 (-0.44, 1.3) ns. 
 
SOS SDS at end of the study 
Median age at discharge was 42 days (24, 69) in the early group and 46 days (23, 110) in the 
late group. There was a significant fall in SOS SDS from study enrolment to hospital 
discharge in both groups; median change was -1.1 (-2.94, -0.44) in the ‘early’ group and -0.8 
(-3.8, -0.25) in the ‘late’ group (both p=0.001)(Figure 6.1). Median SOS SDS at discharge was 
not significantly different between groups -0.6 (-2.2, -0.1) and –1.05 (-1.95, -0.3) in the early 
and late groups respectively (ns). In both groups there were significant correlations between 
 109 
SOS SDS at discharge and both gestation at birth and also birthweight r=0.57, p=0.001, and 
r=0.6, p=0.000 respectively, figure 6.2. 
 
Inpatient Nutrition and Growth 
Median duration of TPN was 7 days (3, 8) in the early group, and 5 days (1, 16) in the late 
group, which was not significantly different. Over the first 3 weeks of life average daily 
intakes of calcium, phosphate and calories did not differ significantly between groups; 1.94 
mmol/kg/day (1.31, 3), 1.55 mmol/kg/day (1.15, 2.57), 112 kcal/kg/day (94, 118) in the early 
group and 2.02 mmol/kg/day (1.31, 4.2), 1.47mmol/kg/day (1.12, 3.12), 104 kcal/kg/day (86, 
129) in the late group (ns). Weight at 3 weeks of age were similar between groups, 1703g 
(1263, 2235), and 1650g (1160, 2441) in the early and late groups respectively (ns.) Weight 
gain over the first 3 weeks were also comparable,  240g (73, 425) in the early group and 115g 
(30, 327) in the late group (ns) In the early group SOS SDS at 3 weeks was -0.6 (-1.1, 0.18), 
which was a median change of -0.8 (-1.46, -0.1) from the start of the study, compared to -0.5 
(-1.4, 0.3) and -0.65 (-1.25, -0.2) in the late group, ns. There was no significant correlation 
between SOS SDS at 3 weeks and daily calcium, phosphate or calorie intake over that period. 
However there was a significant positive correlation between SOS SDS change to discharge 
and both calcium and calorie intake over the first 3 weeks, r=0.54, p=0.018, and r=0.57, 
p=0.011 respectively (figures 6.3 and 6.4). The correlation between SOS SDS until discharge 
and phosphate intake over the first 3 weeks came close to statistical significance, r=0.42, 
p=0.07 (figure 6.3). There was no significant correlation between  average daily weight gain 
until discharge and SOS SDS. 
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Serum Biochemistry 
Median serum alkaline phosphatase (ALP) at discharge was not significantly different 
between groups, 327 iu/l (294, 509) and 278 iu/l (186, 496) in the early and late groups 
respectively. There was also no significant difference between groups in the lowest serum 
phosphate or calcium during the study period, 1.7mmol/l (1.05, 1.87) and 1.97mmol/l (1.85, 
2.1) in the early group compared to 1.59mmol/l (0.98, 1.96) and 1.93mmol/l (1.67, 2.26) in the 
late group. The reference range in our laboratory for serum phosphate is 1.5 -2.6 mmol/l, and 
calcium is 2.2 – 2.7 mmol/l. There was a significant negative correlation between change in 
SOS SDS in both groups and serum ALP at discharge, r=-0.7, p=0.000 (figure 6.5). There was 
also a positive correlation in all infants between SOS SDS until discharge and both lowest 
serum phosphate and also serum calcium, r=0.48, p=0.008 and r=0.55, p=0.002, respectively 
(figure 6.6) Three infants in the early group and 4 infants in the late group had a combination 
of high serum ALP with a concurrently low serum phosphate, suggestive of OP. These infants 
were significantly more preterm ( median gestation 29 weeks compared to 32 weeks), lighter 
at birth (median birthweight 1290g compared to 1700g) and had a greater decrease in SOS 
SDS (median -1.7 compared to -0.8) than the infants without that combination of biochemical 
changes.  
 
Complications of Prematurity 
There were no significant differences in duration of respiratory support between the different 
exercise groups, in the early group median days of ventilation were 0 (0,2) and CPAP were 1 
(0, 4) compared to 1 (0,13) and 1.5 (0, 19) (ns). The number of episodes of proven sepsis were 
also similar, 0 (0, 0.7) and 0 (0, 1.5) in the early and late groups respectively. The rate of 
intraventricular haemorrhage (IVH) and periventricular leukomalacia (PVL) were also not 
significantly different between groups; 2 infants in the early group had an IVH (1 unilateral 
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grade 1, 1 bilateral grade 3) compared to 5 in the late group (3 unilateral grade 1, 1 bilateral 
grade 3, 1 bilateral grade 3/4), and 1 infant from each group developed PVL. Two infants from 
the early group developed chronic lung disease, compared to 3 infants from the late group, No 
infant from either group developed retinopathy of prematurity. One infant from the early 
group and 2 infants from the late group had a persistent ductus arteriosus. No infant developed 
a conjugated hyperbilirubinaemia and there were no fractures noted during the neonatal 
period. 
 
Post discharge growth, bone status and neurodevelopment. 
Twenty six out of the thirty one infants were followed up in the out patient clinic at a median 
age of 12 months (4, 24.) There was no difference in weight, length or OFC, corrected for age, 
between infants who received the early exercise protocol or the late exercise protocol. SOS 
SDS was 0.1 (-1.3, 1.7) in the infants from the early group, and 0.5 (-0.6, 1.0) in the late 
group, ns. One infant from the early group developed post haemorrhagic hydrocephalus, two 
infants from the late group developed a unilateral hemiplegia, one following PVL, the other 
secondary to a middle cerebral artery infarct which was likely to have happened antenatally. 
Two infants from the late group still needed home oxygen at 9 months CGA, one of these 
infants also had sensorineural deafness. No infant was found to have a fracture or any skeletal 
deformity. Fourteen infants were seen as out patients when they had all reached a corrected 
gestational age of 2 years; no infant had a neurodevelopmental abnormality, all having reached 
motor and communication milestones appropriate for their age. (The 2 infants with hemiplegia 
and deafness were not seen at 2 years.) 
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Comparison with historical control group 
Median initial SOS SDS was 0 (-0.4, 1.1) and 0.1(-0.4, 1.1) in the controls for the early and 
late group respectively, this was not significantly different from the early and late exercise 
infants. Median change in SOS SDS was -1.4 (-2.2, -0.85) in the early controls, compared to -
1.1 in the early exercise infants (ns). In the late controls median change in SOS SDS was -1.58 
(-2.2, -0.85) which was a larger decrease over time compared to the late exercise group, 
(median -0.8); the difference was almost statistically significant at p=0.06. Median serum ALP 
at discharge was significantly higher in both control groups, 472IU/l (315, 678) compared to 
the early exercise infants (p=0.04) and late exercise infants (p=0.0008.) 
 
Discussion 
There was no difference in bone SOS in infants who received a physical activity intervention 
starting once immediately cardiovascularly stable, or starting when established on 100kcal/day 
enteral feeds, and neither intervention conferred any benefit compared to a group of historical 
controls. 
 
The same exercise protocol which improved bone mineralisation in the Moyer-Mileur 
studies(56;57) did not have any impact on bone SOS SDS in our study infants. As SOS should 
increase with gestational age, the attenuation in absolute SOS from the same exercise 
intervention as shown by Litmanovitz et al (58), would still result in a decrease in SOS SDS, 
however this would be of a smaller magnitude than in our study group. It is likely that our 
infants did not respond to the physical activity intervention because of suboptimal mineral 
intake. Daily calcium and phosphate was marginally below that recommended for very low 
birthweight infants (17;137), and was substantially lower than the daily intake of infants in the 
Moyer-Mileur study. Infants in both the former studies received fortified EBM, whereas our 
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infants did not. Calorie intake was similar in our infants and the infants in the aforementioned 
studies, and similarly exercise had no significant effect on weight gain. 
 
The correlation between SOS SDS at discharge and early mineral and calorie intake reinforces 
the importance of striving for the best possible nutrition in preterm infants. As observed in our 
earlier studies (119) the most preterm infants had the largest negative change in SOS SDS 
from birth to discharge, and they are the group who pose the greatest challenge in provision of 
good nutrition. Trying to improve bone health by challenging immobility using a physical 
exercise programme appears less effective in the presence of suboptimal intake of calcium and 
phosphate. However, there was an effect on serum alkaline phosphate at the end of the study, 
interestingly ALP was lower in infants who received physical activity compared to the group 
of historical controls, perhaps reflecting a positive effect of exercise on bone turnover, with 
reduced bone resorption at hospital discharge. This may be important in the risk of subsequent 
fracture and long term growth. 
 
This is the first study to look at complications and medium term outcomes of a physical 
activity programme. A recent Cochrane review on the effects of exercise in preterm infants 
(138) concluded that the current data were inadequate to assess the possibility that exercise 
may be harmful. There were no fractures or skeletal deformities found on follow up of our 
study group. Growth and bone strength assessed by QUS were neither negatively affected nor 
improved by having either of the physical activity protocols during the neonatal period. Our 
study has many limitations, particularly the small numbers involved, and the large proportion 
of twins and greater numbers would be needed to establish the safety of passive exercises in 
this population.  
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Our data raises the possibility that nutritional intake may modify the effect of physical 
activity. There was no difference in outcomes between exercise that started early or late. The 
optimal physical activity programme for preterm infants remains undetermined and there is a 
need to explore the interaction between nutritional status and exercise. Future studies 
including comparison between intervention groups and contemporaneous controls are 
required. 
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Table 6.1 
 
Early  Group Late  Group   
Median 10th, 90th centiles Median 10th, 90th centiles P value 
Gestation 30 27.4, 33 31.5 27.5, 33 0.89 
Birthweight 1525 1126, 2002 1560 985, 2255 0.77 
Weight discharge 2510 2042, 3220 2525 2058, 3215 0.84 
OFC1 birth 29.5 26.5, 30.5 30 26.8, 32.3 0.24 
OFC discharge 32.6 32.1, 34.7 34.7 33.3, 36.8 0.06 
Initial SOS 2986 2864, 3098 2982 2874, 3086  
SOS discharge 2932 2785, 3038 2900 2826, 2992  
Initial SOS SDS  0.4 -0.8, 1.3 0.1 -0.55, 1.3 0.43 
SOS SDS discharge -0.6 -2.2, -0.1 -1.0 -1.95, -0.3 0.68 
Days of exercise 24 14, 38 21 10, 50 0.90 
Age at discharge 42 24, 69 45 22.5, 110 0.79 
Days ventilation 0 0, 2 1 0, 13 0.25 
Days CPAP2 1 0, 4 1.5 0, 19 0.53 
Days TPN3 6.5 3.3, 8 4.5 0.5, 6 0.50 
Incidents4 0.1 0, 1.4 0.1 0, 0.7 0.81 
Sepsis episodes 0 0, 0.7 0 0, 1.5 0.31 
Serum PO45 1.7 1.05, 1.87 1.59 0.98. 1.96 0.69 
Serum calcium 1.97 1.85, 2.1 1.93 1.67, 2.23 0.60 
Serum ALP6  327 239, 509 278 186, 496 0.42 
No infants CLD7 2 3  
No infants IVH8 2 5  
No infants PVL9 1 1  
No infants ROP10 0 0  
 
Table 6.1 Characteristics of Early and Late Groups 
1- OFC, occipitofrontal circumference , 2- CPAP, continuous positive airways pressure, 3- 
TPN, total parenteral nutrition, 4- Incidents, number of episodes of apnoea, bradycardia or 
desaturation, 5- PO4, serum phosphate, 6- ALP, serum total alkaline phosphatase, 7- CLD, 
chronic lung disease, oxygen dependent after 36 weeks corrected gestational age, 8- IVH, 
intraventricular haemorrhage, 9- PVL, periventricular leukomalacia, 10- ROP, retinopathy of 
prematurity. 
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Figure 6.1 
 
 
The boxplot shows change in SOS SDS from start to end of study period. The straight line 
represents the median, and the whiskers show the interquartile range. The diamond shape 
represents an outlier. 
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Figure 6.2 
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The closed circles represent each infants change in SOS SDS from start to the end of the study 
period. 
 118 
 
Figure 6.3 
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The black circles represent values for each patient’s change in SOS SDS until hospital 
discharge plotted by average daily calcium intake (mmol/kg/day) over the first 3 weeks of life. 
The black squares represent values for each patient’s change in SOS SDS until hospital 
discharge plotted by average daily phosphate intake over the first 3 weeks of life. 
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Figure 6.4 
 
 
 
The closed circles represent each patient’s change in SOS SDS from start of the study until 
hospital discharge plotted by their average calorie intake (kg/kg/day) over the first 3 weeks of 
life. 
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Figure 6.5 
 
 
 
The closed circles represent each patient’s change in SOS SDS until hospital discharge plotted 
with their serum alkaline phosphatase (ALP, iu/l) at hospital discharge. 
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Figure 6.6 
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The closed circles represent each patient’s change in SOS SDS until hospital discharge plotted 
against their lowest serum calcium during the neonatal period (mmol/l.) 
 122 
Chapter 7 Conclusions and Future Directions 
Conclusion 
The work of this thesis establishes quantitative ultrasound as a useful technique in the 
assessment of infant bone health. It is a radiation free tool which provides precise and 
reproducible measurements in both term and preterm infants. The pattern of speed of sound 
changes in a neonatal population was assessed, and then used to assess the effect of a clinical 
intervention.   
In agreement with a small number of other studies we found that preterm infants have a lower 
speed of sound at birth compared to term infants; speed of sound increases with increasing 
gestation while in utero. By including infants who were both appropriately grown and small 
for gestational age we found maturity to be a more important factor in bone strength than 
birthweight. In infants born before 32 weeks speed of sound decreases from birth to term 
corrected gestational age, this decline was largest in the sickest, most preterm infants but 
occurred in all study infants. The low SOS close to term CGA coincides with the peak time for 
fractures secondary to osteopenia of prematurity. From term to 2 years CGA tibial speed of 
sound in preterm infants increases rapidly, exhibiting a catch up phenomenon which, in the 
majority, produced SOS values in the normal range by 6 months CGA. This trajectory of SOS 
is similar to bone changes demonstrated in preterm infants using SPA and DXA(37-43), and 
reflects the common clinical course of neonatal bone disease due to osteopenia of prematurity. 
Despite the apparent self limiting nature of osteopenia of prematurity an intervention to 
improve neonatal bone health is still desirable; to prevent fractures which occur in up to 10% 
of cases (29;31) and to prevent long term effects on growth (45-47;50). Passive exercise has 
been used successfully in a few studies (56-58) to improve bone health in the short term in 
preterm infants, however those studies lacked information on benefits and harm in the longer 
term. Optimal duration and timing of exercise remains unclear; our study of an ‘early’ versus 
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‘late’ physical activity programme was designed to explore the benefit versus harm of extra 
handling of preterm infants at the earliest opportunity (when cardiovascularly stable) 
compared to the same passive exercises when the infants were older but had a better mineral 
supply. In both groups there was a significant fall in SOS from birth to hospital discharge, of a 
similar magnitude to gestation matched historical controls. There was no significant difference 
between the exercise groups in SOS to discharge, serum bone biochemistry and growth. It is 
likely that suboptimal mineral intake in our study infants affected the response to the physical 
activity programme. The changes in SOS SDS correlated strongly with early nutritional intake 
of phosphate, calcium and kilocalories.  Our results challenge conclusions from previous 
studies that physical activity alone can improve neonatal bone health. No significant adverse 
effects occurred secondary to physical activity during the neonatal period or in the first year of 
life. There were two main drawbacks to the study, the small numbers of infants recruited, and 
the limitation of the technique of quantitative ultrasound. Recruitment to the cross-sectional 
and interventional studies of preterm infants was limited due to smaller than expected numbers 
of preterm infants being delivered at the recruiting centre. It is possible that the small sample 
size of our study may have underestimated either the benefits of exercise or associated 
complications.  Larger studies are needed to define better the role of passive exercise in the 
neonatal period. QUS is reported to measure both qualitative bone properties, such as bone 
mineralization, and quantitative properties such as cortical thickness, elasticity and micro 
architecture (71-74) but exact correlations are not clear at present.  In adults, QUS predicts 
clinical fractures independent of BMD (75;76), but this has not yet been demonstrated in 
children and infants. Therefore there is currently no role for quantitative ultrasound in routine 
clinical practice in neonatology. 
In the west of Scotland vitamin D deficiency is common in pregnancy, and women of south 
asian origin are at particularly high risk.  SOS was normal in most women at the start of 
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pregnancy, even those with risk factors for adverse bone health. It is likely that osteomalacia is 
not seen immediately upon vitamin D becoming deficient, and therefore changes in SOS may 
take some time to evolve and may not be seen at booking or at delivery depending on the 
duration and severity of vitamin D deficiency. Term fetuses appear relatively protected and at 
birth have normal bone strength. There may be short term consequences relating to calcium 
metabolism in the vitamin D deficient neonate. Preterm and term infants may be susceptible to 
the effect of programming; therefore there are potentially longer term effects on the 
cardiovascular system, risk of cancer and bone disease. Vitamin D supplementation should be 
given to pregnant women, particularly those at high risk.  
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Future Directions 
‘Imagination is more important than knowledge. For while knowledge defines all we currently 
know and understand, imagination points to all we might yet discover and create’ (Albert 
Einstein) 
 
There are unanswered questions in the current literature which stem from my project 
• What is the relationship between QUS measurements and risk of fracture in preterm 
infants? 
There is a need to define the true incidence of fracture in preterm infants via a 
prospective study.  A multicentre study which actively screened for fractures at 
discharge would be desirable. 
• What is the optimal physical activity programme for infants born prematurely? 
Larger randomised controlled studies of physical activity in neonates are needed to 
determine an optimal exercise regimen, which must be considered alongside mineral 
and nutrient supply. Follow up for at least 2 years would be desirable. The role of 
genetic influences such as the vitamin D receptor merits further investigation within 
the infant population and could be done easily on umbilical cord blood. 
•  How many infants and children will present with clinical consequences of vitamin D 
deficiency in Scotland, and what are the longer term outcomes of women and children 
with vitamin D deficiency? 
Future studies should focus on functional outcomes of vitamin D deficiency; this was 
outwith the scope of this thesis. A national surveillance programme of infants and 
children presenting with vitamin D deficiency with long follow up would be needed to 
provide accurate information. As there is the potential for vitamin D deficiency to 
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affect many systems longitudinal evaluation of bone health, growth, cardiovascular 
system and occurrence of malignancy would be necessary. 
. 
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Photograph 1 
 
 
Photograph 2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Photographs 1 and 2 show a tibial quantitative ultrasound scan being done on a preterm 
infant. 
 128 
Photograph 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Photograph 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Photographs 3 and 4 show preterm infants receiving passive exercises. 
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